Diseases of the myoneural junction and muscle

G6_MYONEU

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G70-G73, G71.10#, G71.11, G71.12, G71.13, G71.14, G71.15, G71.18 Cause of death: ICD-10 — G70-G73, G71.10#, G71.11, G71.12, G71.13, G71.14, G71.15, G71.18 2 out of 7 registries used, show all original rules.	4738
4. Check minimum number of events None	4738
5. Include endpoints G6_MYASTHENIA G6_TOXMYONEU G6_CONDEVMYA G6_MYONEUOTHUNS G6_MUSDYST G6_MYOTDIS G6_CONMYOP G6_MITOCMY G6_MUSCOTHUNS G6_DRUGMYOP G6_ALCOMYOP G6_MYOPTOX G6_PERIOPAR G6_INFLAMYOP G6_MYOPOTHUNS G6_MYOMUSCINOTH	4828
6. Filter based on genotype QC (FinnGen only)	4828

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	G6_MYONEU
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_MYASTHENIA\|G6_TOXMYONEU\|G6_CONDEVMYA\|G6_MYONEUOTHUNS\|G6_MUSDYST\|G6_MYOTDIS\|G6_CONMYOP\|G6_MITOCMY\|G6_MUSCOTHUNS\|G6_DRUGMYOP\|G6_ALCOMYOP\|G6_MYOPTOX\|G6_PERIOPAR\|G6_INFLAMYOP\|G6_MYOPOTHUNS\|G6_MYOMUSCINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G7
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G7
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diseases of the myoneural junction and muscle based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	42435	19202	22973
Only index persons	37440	17431	20009
Unadjusted period prevalence (%)
Whole population	0.60	0.55	0.64
Only index persons	0.71	0.64	0.76
Median age at first event (years)
Whole population	64.79	68.78	61.48
Only index persons	65.24	69.09	61.88

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4828	2222	2606
Unadjusted period prevalence (%)	0.97	0.76	1.15
Median age at first event (years)	60.83	58.68	62.67

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4313: Matched controls
43130

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G70.0

ICD-10 Finland

Myasthenia gravis

5321.0

323.0

485

N07AA02

ATC

pyridostigmine; systemic

414.6

323.0

450

G72.9

ICD-10 Finland

Myopathy, unspecified

4177.7

323.0

1010

108

Kela drug reimbursment

Myasthenia gravis

+∞

323.0

382

G72.8

ICD-10 Finland

Other specified myopathies

12638.3

323.0

2077

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.8

236.0

1228

4121

AA1AD

NOMESCO Finland

CT of head and brain

3.2

225.8

1573

6573

G71.08

ICD-10 Finland

Other muscular dystrophy

970.2

191.1

186

G71.9

ICD-10 Finland

Primary disorder of muscle, unspecified

1918.5

181.4

175

L28

ICPC

Limited function/disability (L)

3.3

176.1

1086

4027

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.4

171.3

689

1777

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.8

161.2

584

1349

NXL00

NOMESCO Finland

Biopsy of muscle

65.5

151.5

176

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

+∞

136.1

130

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

55.3

134.1

160

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.4

132.8

1608

8672

A28

ICPC

Limited function/disability NOS

2.9

130.9

960

3902

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.8

128.7

974

4033

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.9

125.4

375

687

G71.18

ICD-10 Finland

Other myotonic disease

+∞

120.4

115

N05AH04

ATC

quetiapine; oral

2.8

119.4

912

3776

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.4

118.2

380

758

L04AX01

ATC

azathioprine; systemic

5.2

110.9

369

764

G71.11

ICD-10 Finland

Dystrophia myotonica [Steinert]

+∞

110.9

106

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

52.3

109.7

132

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

109.2

1319

6954

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

107.1

703

2621

R53

ICD-10 Finland

Malaise and fatigue

2.4

104.7

1098

5376

G71.8

ICD-10 Finland

Other primary disorders of muscles

+∞

102.5

G70.9

ICD-10 Finland

Myoneural disorder, unspecified

+∞

101.4

N03AE01

ATC

clonazepam; systemic

4.1

101.4

429

1131

N99

ICPC

Neurological disease other

13.1

100.9

182

144

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.4

100.1

277

457

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.4

98.3

388

957

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

97.4

2058

13592

N05BA01

ATC

diazepam; systemic, rectal

2.7

96.5

773

3247

M60.9

ICD-10 Finland

Myositis, unspecified

30.4

94.1

127

G72.0

ICD-10 Finland

Drug-induced myopathy

472.9

93.7

NGA20

NOMESCO Finland

Exploration of soft tissue knee or lower leg, open

34.8

93.5

122

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

917.6

92.2

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.4

91.9

484

1530

SPAT1216

SPAT

Assessment of functional ability

2.5

91.7

865

3970

N05AH03

ATC

olanzapine; systemic

3.9

91.3

405

1111

N05AA02

ATC

levomepromazine; systemic

4.7

90.6

328

740

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.7

90.3

429

1247

SPAT1229

SPAT

Assessment of need for aid

3.2

90.3

524

1779

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.7

88.2

419

1217

N03AX16

ATC

pregabalin; oral

2.2

87.9

1155

6212

G71.12

ICD-10 Finland

Myotonia congenita

+∞

87.8

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

85.8

834

3873

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

85.2

899

4353

C03CA01

ATC

furosemide; systemic

2.0

84.6

1478

8921

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

84.0

1496

9090

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.7

81.6

618

2490

N06AX11

ATC

mirtazapine; oral

2.0

81.0

1446

8769

N03AG01

ATC

valproic acid; systemic, rectal

3.5

81.0

405

1224

N06AB04

ATC

citalopram; systemic

2.2

79.9

1018

5362

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.0

79.7

232

407

GEC24

NOMESCO Finland

Thoracoscopic thymectomy

123.8

79.2

N05CD07

ATC

temazepam; oral

2.5

78.0

719

3232

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

76.4

703

3151

M60.8

ICD-10 Finland

Other myositis

79.8

76.3

H53.2

ICD-10 Finland

Diplopia

5.2

75.7

249

505

M33.2

ICD-10 Finland

Polymyositis

67.4

74.6

N05BA04

ATC

oxazepam; oral

2.0

73.1

1140

6502

SPAT1254

SPAT

Administration of medicine

2.3

72.3

790

3855

Z31.5

ICD-10 Finland

Genetic counselling

4.3

71.1

282

694

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.9

71.1

184

276

R1250

NOMESCO Finland

Evaluation of functional capability

6.1

70.8

203

349

SPAT1231

SPAT

Assessment of adjustments needed in living environment

6.3

70.4

195

321

N03AX12

ATC

gabapentin; oral

2.3

69.5

767

3752

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.9

69.1

457

1681

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

9.5

68.7

145

157

N05AX08

ATC

risperidone; systemic

2.8

68.6

478

1819

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.9

68.3

177

266

N28

ICPC

Limited function/disability (N)

7.6

68.2

165

224

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.7

65.8

304

857

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.9

65.3

168

250

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

65.1

500

2016

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.2

64.3

260

651

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

63.4

708

3470

N05AF03

ATC

chlorprothixene; systemic

5.2

63.0

206

415

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

62.7

429

1610

A04

ICPC

Weakness/tiredness general

2.3

61.6

639

3019

SPAT1234

SPAT

Support of social functional capacity

3.3

61.0

333

1070

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

61.0

1262

7888

N05CF01

ATC

zopiclone; oral

1.8

60.9

1430

9326

A02BC02

ATC

pantoprazole; systemic

1.7

60.5

2700

21339

R13

ICD-10 Finland

Dysphagia

3.0

59.7

377

1341

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

59.6

654

3170

H02.4

ICD-10 Finland

Ptosis of eyelid

4.8

59.1

205

440

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.9

58.3

380

1381

P15

ICPC

Chronic alcohol abuse

4.8

58.0

202

436

H02AB06

ATC

prednisolone; systemic

1.7

57.6

1969

14320

F10.24

ICD-10 Finland

Alcohol depence active use

7.5

57.5

140

192

N07AA03

ATC

distigmine; systemic

20.2

57.5

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.6

57.1

152

237

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

57.0

851

4700

N07BB01

ATC

disulfiram; oral

3.6

56.5

273

798

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.5

56.4

279

830

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

55.7

1268

8133

N29

ICPC

Neurological sympt/complt other

5.7

55.5

165

297

N06AX21

ATC

duloxetine; oral

2.5

54.6

487

2124

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.8

53.8

158

280

R03CA02

ATC

ephedrine; oral

58.1

53.6

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

53.6

811

4490

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

7.7

53.3

127

169

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.7

53.2

404

1609

G71.00

ICD-10 Finland

Muscular dystrophy benign [Becker]

+∞

53.2

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.6

53.1

409

1643

N06AA09

ATC

amitriptyline; systemic

2.4

52.8

508

2301

N03AX09

ATC

lamotrigine; oral

3.6

52.6

249

715

N06AX16

ATC

venlafaxine; oral

2.2

52.4

585

2844

E86

ICD-10 Finland

Volume depletion

4.6

52.4

189

423

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

52.2

485

2156

3580A

ICD-9 Finland

Myoneural disorders, Myasthenia gravis

+∞

52.2

TAB00

NOMESCO Finland

Lumbar puncture

3.6

51.9

251

733

A46

ICD-10 Finland

Erysipelas

2.1

51.9

686

3592

W19

ICD-10 Finland

Unspecified fall

2.4

51.8

483

2153

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

51.6

644

3290

S01.0

ICD-10 Finland

Open wound of scalp

2.6

50.5

406

1668

N02BE01

ATC

paracetamol; systemic, rectal

1.8

50.4

3548

31045

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.7

50.3

149

267

R4110

NOMESCO Finland

Physiotherapy

1.8

50.3

1145

7297

S06.0

ICD-10 Finland

Concussion

2.3

48.2

492

2288

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.5

47.8

237

706

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

5.1

47.1

154

310

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.0

47.0

157

324

F05.9

ICD-10 Finland

Delirium, unspecified

5.0

46.8

155

317

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.1

46.7

268

890

WX892

NOMESCO Finland

Monitored bed care

2.5

46.6

395

1669

M62.9

ICD-10 Finland

Disorder of muscle, unspecified

21.2

46.6

N05BA02

ATC

chlordiazepoxide; systemic

4.4

46.5

175

409

SPAT1172

SPAT

Guidance concerning hydration

4.3

46.4

178

424

G72.4

ICD-10 Finland

Inflammatory myopathy, not elsewhere classified

+∞

45.9

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

45.7

377

1569

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

10.5

45.5

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

45.1

301

1106

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

8.8

44.3

113

A06AD11

ATC

lactulose; oral

1.9

44.1

699

3911

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.0

43.9

184

476

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

43.9

621

3323

N05BA06

ATC

lorazepam; systemic, sublingual

2.9

43.7

283

1020

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.5

43.6

212

622

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.9

43.0

147

311

G73.7

ICD-10 Finland

Myopathy in other diseases classified elsewhere

151.5

42.8

NF1AA

NOMESCO Finland

Hip X-ray examination

2.3

42.2

415

1890

N03AF01

ATC

carbamazepine; oral, rectal

2.8

42.1

286

1061

N17.8

ICD-10 Finland

Other acute renal failure

7.1

42.1

105

150

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.7

42.1

301

1151

N06AB03

ATC

fluoxetine; oral

2.1

41.8

525

2673

73300

ICD-8 Finland

Other diseases of muscle, tendon and fascia, Myasthenia gravis

+∞

41.7

N02AX02

ATC

tramadol; systemic, rectal

1.6

41.7

1737

12928

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

40.6

327

1340

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.6

40.6

194

561

N05AH02

ATC

clozapine; systemic

5.3

40.2

127

247

R60.0

ICD-10 Finland

Localized oedema

2.1

39.9

500

2537

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

39.6

604

3321

A41.9

ICD-10 Finland

Sepsis, unspecified

3.2

39.5

224

736

R06.0

ICD-10 Finland

Dyspnoea

1.7

39.4

1024

6705

L19

ICPC

Muscle symptom/complaint NOS

4.2

39.1

154

376

R41.0

ICD-10 Finland

Disorientation, unspecified

3.5

39.1

193

573

S97

ICPC

Chronic ulcer skin

2.7

39.1

287

1116

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

38.8

503

2592

G70

ICD-10 Finland

Myasthenia gravis and other myoneural disorders

+∞

38.6

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

7.8

38.3

118

N04AA02

ATC

biperiden; systemic

4.7

38.3

135

296

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.9

38.1

129

271

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.7

38.0

274

1054

C07AA05

ATC

propranolol; systemic

1.8

37.9

733

4373

SPAT1301

SPAT

No procedures

1.6

37.8

1308

9234

N05BA12

ATC

alprazolam; oral

2.1

37.7

446

2209

TNX05

NOMESCO Finland

Simple incision of soft tissue, unspecified region

50.5

37.6

M79.6

ICD-10 Finland

Pain in limb

1.6

37.6

1366

9762

N06AB06

ATC

sertraline; oral

2.2

37.5

429

2093

L99

ICPC

Musculoskeletal disease other

4.8

37.5

130

280

E87.6

ICD-10 Finland

Hypokalaemia

3.6

37.4

176

503

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

37.1

530

2835

H02AB07

ATC

prednisone; oral

1.9

37.0

620

3518

TK800

NOMESCO Finland

Hemodialysis

4.0

36.9

151

383

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

36.7

322

1382

R42

ICD-10 Finland

Dizziness and giddiness

1.7

36.7

895

5735

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.1

36.6

148

371

G72.1

ICD-10 Finland

Alcoholic myopathy

+∞

36.5

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

36.2

425

2096

C07AB07

ATC

bisoprolol; oral

1.5

36.2

1956

15295

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

35.9

891

5734

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.5

35.7

131

299

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

35.6

679

4025

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

35.5

328

1445

G71.0

ICD-10 Finland

Muscular dystrophy

+∞

35.5

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

35.3

261

1017

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

35.3

349

1588

R50.9

ICD-10 Finland

Fever, unspecified

1.9

35.0

600

3428

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.8

35.0

135

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

35.0

494

2625

N06AA12

ATC

doxepin; systemic

2.6

35.0

269

1073

N02AA05

ATC

oxycodone; systemic

1.8

34.0

640

3772

M05BA04

ATC

alendronic acid; oral

2.2

34.0

373

1784

J01DB01

ATC

cefalexin; oral

1.6

33.9

3261

28731

N18

ICPC

Paralysis/weakness

4.3

33.5

129

309

N05AD01

ATC

haloperidol; systemic

3.2

33.5

182

582

3599X

ICD-9 Finland

Muscular dystrophies and other myopathies, Myopathy, unspecified

+∞

33.4

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.0

32.9

155

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

32.7

433

2241

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.5

32.7

262

1069

G72

ICD-10 Finland

Other myopathies

+∞

32.3

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

32.2

346

1638

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

32.1

589

3438

N05BE01

ATC

buspirone; oral

3.4

31.8

161

488

N06AB10

ATC

escitalopram; oral

1.7

31.8

728

4555

M79.1

ICD-10 Finland

Myalgia

1.9

31.6

500

2770

N06AX03

ATC

mianserin; oral

2.7

31.5

232

903

N05AA01

ATC

chlorpromazine; systemic, rectal

5.5

31.5

176

G71.28

ICD-10 Finland

Other congenital myopathy

+∞

31.3

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

31.1

350

1693

GEC23

NOMESCO Finland

Transsternal thymectomy

315.1

30.9

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.5

30.7

169

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.5

30.5

145

419

T68

ICD-10 Finland

Hypothermia

9.1

30.3

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

8.0

30.2

G71.06

ICD-10 Finland

Muscular dystrophy severe [Duchenne]

+∞

30.2

5872

FHL

Thymic exploration or thymectomy

+∞

30.2

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

+∞

30.2

NJ3DG

NOMESCO Finland

Very extensive MRI examination of extremities with high intensity magnet

38.3

30.2

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

30.2

192

684

SPAT1167

SPAT

Insertion of urinary catheter

3.0

30.1

179

610

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

29.7

373

1889

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

29.7

856

5702

A29

ICPC

General symptom/complaint other

1.9

29.6

458

2511

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.2

29.5

115

280

R4120

NOMESCO Finland

Occupational therapy

2.3

29.4

279

1244

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

5.1

29.3

187

S18

ICPC

Laceration/cut

1.5

29.3

1638

12709

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

29.0

690

4355

J96.1

ICD-10 Finland

Chronic respiratory failure

3.7

29.0

131

363

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

29.0

451

2477

N05CF02

ATC

zolpidem; oral

1.7

28.9

658

4100

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

10.7

28.9

N05AC02

ATC

thioridazine; oral

4.1

28.9

116

290

G70.8

ICD-10 Finland

Other specified myoneural disorders

293.9

28.8

N05AX12

ATC

aripiprazole; systemic

3.1

28.7

164

543

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.8

28.6

123

327

N03AX14

ATC

levetiracetam; systemic

3.3

28.3

145

444

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

28.3

275

1240

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

28.1

274

1239

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

28.0

608

3730

A02BC01

ATC

omeprazole; systemic

1.5

28.0

1106

7945

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

27.9

394

2089

N05AN01

ATC

lithium; oral

3.7

27.8

125

345

Z72.1

ICD-10 Finland

Alcohol use

5.1

27.7

178

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

27.5

292

1374

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

27.2

357

1837

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

27.2

409

2220

P72

ICPC

Schizophrenia

4.3

27.2

104

249

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.1

27.1

152

498

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

26.8

274

1266

A01

ICPC

Pain general/multiple sites

2.1

26.8

323

1605

F34.1

ICD-10 Finland

Dysthymia

3.1

26.7

149

487

E0000UV

ATC

1.5

26.6

1454

11163

WX730

NOMESCO Finland

Conventional respirator

4.2

26.6

104

254

N05AB03

ATC

perphenazine; systemic, rectal

2.8

26.5

174

632

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.8

26.4

174

635

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

26.4

857

5866

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

5.3

26.4

154

P29

ICPC

Psychological sympt/compl other

2.5

26.2

209

852

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

7.3

26.1

SPAT1240

SPAT

Therapeutic discussion

2.0

26.1

371

1970

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.7

26.0

186

711

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.0

25.9

170

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

25.7

246

1099

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.1

25.6

148

495

R55

ICD-10 Finland

Syncope and collapse

1.8

25.5

464

2690

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.6

25.4

136

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

5.0

25.4

165

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.6

25.1

117

334

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

25.1

326

1671

M62.8

ICD-10 Finland

Other specified disorders of muscle

16.1

24.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

24.8

399

2215

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

26.3

24.8

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.6

24.8

190

757

R51.80

ICD-10 Finland

Headache

1.7

24.7

523

3178

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.8

24.7

175

J01FF01

ATC

clindamycin; systemic

1.5

24.6

1033

7487

A12BA01

ATC

potassium chloride; oral

2.3

24.5

234

1048

M48.0

ICD-10 Finland

Spinal stenosis

1.7

24.5

504

3036

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

8.9

24.4

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

12.8

24.3

SPAT1262

SPAT

Handing over of treatment supplies

1.6

24.3

739

4965

XA402

NOMESCO Finland

ENMG

3.3

24.2

125

387

N30.0

ICD-10 Finland

Acute cystitis

1.7

24.1

509

3088

B18.2

ICD-10 Finland

Chronic viral hepatitis C

5.9

24.1

117

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

24.0

161

594

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

24.0

434

2509

G71.02

ICD-10 Finland

Muscular dystrophy facioscapulohumeral

+∞

24.0

G71.25

ICD-10 Finland

Congenital muscular dystrophy NOS

+∞

24.0

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.1

23.6

149

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

23.4

428

2483

J01MA12

ATC

levofloxacin; systemic

1.6

23.3

736

4982

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

23.2

222

993

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

5.3

23.2

135

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.0

23.1

323

1700

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

23.1

259

1248

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

23.0

643

4219

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

23.0

708

4760

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

22.2

23.0

C03DA01

ATC

spironolactone; oral

1.8

23.0

447

2644

G70.28

ICD-10 Finland

Other congenital and developmental myasthenia

+∞

22.9

G71.03

ICD-10 Finland

Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker

+∞

22.9

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

22.9

328

1745

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.6

22.9

176

704

SPAT1263

SPAT

Sampling

1.4

22.9

1616

12924

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

22.7

1017

7446

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

13.1

22.4

P99

ICPC

Psychological disorders other

3.2

22.3

117

367

M62.5

ICD-10 Finland

Muscle wasting and atrophy, not elsewhere classified

19.5

22.1

T79.6

ICD-10 Finland

Traumatic ischaemia of muscle

9.9

22.0

G73.0*E05.9

ICD-10 Finland

Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]

+∞

21.9

G72.3

ICD-10 Finland

Periodic paralysis

+∞

21.9

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.6

21.9

171

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

21.8

295

1533

E87.2

ICD-10 Finland

Acidosis

8.4

21.8

WX872

NOMESCO Finland

Intensive care

2.2

21.8

220

1009

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.4

21.8

107

319

R33

ICD-10 Finland

Retention of urine

1.9

21.7

345

1906

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

11.5

21.7

R4130

NOMESCO Finland

Speech therapy

3.3

21.5

110

339

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

21.4

924

6699

V03AA01

ATC

3.5

21.4

100

287

R47.1

ICD-10 Finland

Dysarthria and anarthria

5.3

21.4

127

P16

ICPC

Acute alcohol abuse

4.0

21.4

222

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.9

21.3

129

446

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.6

21.3

158

617

N03AF02

ATC

oxcarbazepine; oral

2.7

21.3

151

576

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.9

21.2

135

483

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

21.2

318

1719

J01DA01

ATC

[U] cefalexin; systemic

1.4

21.2

2403

20716

L04AA06

ATC

mycophenolic acid; systemic

3.7

21.2

259

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

21.1

1448

11480

P01BA02

ATC

hydroxychloroquine; oral

1.9

21.0

311

1675

Z72.2

ICD-10 Finland

Drug use

9.9

21.0

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.2

20.9

110

346

N06AA06

ATC

trimipramine; systemic

3.1

20.9

119

394

3591A

ICD-9 Finland

Muscular dystrophies and other myopathies, Hereditary progressive muscular dystrophy

+∞

20.8

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.2

20.8

110

347

Z50.1

ICD-10 Finland

Other physical therapy

2.1

20.8

235

1135

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

20.8

1162

8864

M54.5

ICD-10 Finland

Low back pain

1.4

20.7

1157

8827

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

20.7

1263

9795

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

8.7

20.5

WX882

NOMESCO Finland

High dependency care

2.7

20.5

143

542

G41.9

ICD-10 Finland

Status epilepticus, unspecified

6.9

20.4

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

20.4

338

1895

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.8

20.4

237

A02BC05

ATC

esomeprazole; systemic

1.4

20.3

1487

11894

N05AL01

ATC

sulpiride; systemic

4.0

20.3

213

WX110

NOMESCO Finland

Local anesthesy

1.4

20.3

2529

22054

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

10.1

20.3

ZZA00

NOMESCO Finland

Split skin graft

2.6

20.3

148

574

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

20.3

890

6469

X58

ICD-10 Finland

Exposure to other specified factors

1.7

20.2

504

3198

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

20.2

183

798

Y94.0

ICD-10 Finland

Accident at home

3.4

20.2

101

306

H02AB09

ATC

hydrocortisone; systemic

3.1

20.2

115

381

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

20.2

244

1214

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.7

20.1

145

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.8

20.1

129

465

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.9

20.0

133

D21

ICPC

Swallowing problem

4.3

20.0

178

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

19.9

620

4171

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

19.8

1142

8747

G73.1*C80.99

ICD-10 Finland

Eaton-Lambert syndrome

+∞

19.8

N05AF05

ATC

zuclopenthixol; systemic

4.8

19.8

139

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.8

19.8

129

468

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

19.7

275

1450

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

19.6

171

733

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

19.6

123

435

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

19.6

1464

11736

M03BX01

ATC

baclofen; systemic

3.7

19.5

241

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

3.8

19.5

221

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

19.5

462

2893

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.4

19.5

164

L76

ICPC

Fracture: other

2.9

19.4

122

431

S22.3

ICD-10 Finland

Fracture of rib

2.0

19.4

266

1394

K08.3

ICD-10 Finland

Retained dental root

1.9

19.3

277

1472

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.3

19.3

100

312

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.9

19.2

204

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

19.2

646

4426

H03AA01

ATC

levothyroxine sodium; systemic

1.5

19.1

788

5642

G62.8

ICD-10 Finland

Other specified polyneuropathies

5.7

19.1

G70.1

ICD-10 Finland

Toxic myoneural disorders

+∞

18.8

G70.20

ICD-10 Finland

Congenital and developmental myasthenia

+∞

18.8

N06AX26

ATC

vortioxetine; oral

2.2

18.7

194

902

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

18.7

285

1551

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.6

18.7

142

563

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

18.7

186

848

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

18.7

123

450

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.5

18.7

146

591

K70.1

ICD-10 Finland

Alcoholic hepatitis

6.3

18.6

R52.2

ICD-10 Finland

Other chronic pain

2.6

18.6

138

541

N06AX05

ATC

trazodone; oral

3.0

18.6

110

377

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

18.5

279

1512

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

11.4

18.4

XF404

NOMESCO Finland

Ambulatory ECG

1.7

18.2

368

2197

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

11.0

18.2

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

8.9

18.1

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.9

18.1

191

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.3

18.1

273

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

18.0

419

2605

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.2

18.0

168

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.6

17.9

130

504

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

17.9

309

1756

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

16.6

17.8

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.3

17.8

170

762

P18

ICPC

Medication abuse

7.7

17.8

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.4

17.7

147

M33.1

ICD-10 Finland

Other dermatomyositis

22.8

17.7

G73.0*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic amyotrophy

+∞

17.7

G72.2

ICD-10 Finland

Myopathy due to other toxic agents

+∞

17.7

GEC26

NOMESCO Finland

Mediastinoscopic thymectomy

+∞

17.7

F61.0

ICD-10 Finland

Mixed personality disorders

3.7

17.7

210

33098

ICD-8 Finland

Hereditary neuromuscular disorders, Alii definiti

180.7

17.5

Z71.8

ICD-10 Finland

Other specified counselling

1.5

17.5

805

5886

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

17.4

1174

9203

G12.8

ICD-10 Finland

Other spinal muscular atrophies and related syndromes

28.9

17.4

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.2

17.3

102

S70.0

ICD-10 Finland

Contusion of hip

2.4

17.3

153

661

L29

ICPC

Musculoskeletal sympt/complt other

1.9

17.3

269

1475

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

17.2

2239

19415

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

17.2

377

2307

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.8

17.1

109

390

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

17.1

1033

7942

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

17.1

986

7519

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.1

17.1

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

17.0

387

2391

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

17.0

151

654

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

17.0

237

1247

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

4.7

17.0

122

A99

ICPC

Disease/condition unspecnature/site

1.8

16.9

292

1658

XG466

NOMESCO Finland

Sleep oxymetry

2.4

16.9

144

610

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

16.9

408

2564

SPAT1360

SPAT

Extensive global examination

1.8

16.9

290

1645

U04

ICPC

Incontinence urine

2.2

16.8

178

839

EBA00

NOMESCO Finland

Extraction of tooth

1.4

16.7

1152

9057

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

16.7

496

3293

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.4

16.6

237

S00.0

ICD-10 Finland

Superficial injury of scalp

3.0

16.5

337

SPAT1251

SPAT

Organisation of medication

2.2

16.4

163

744

P03

ICPC

Feeling depressed

1.8

16.4

269

1500

T51.0

ICD-10 Finland

Toxic effect: Ethanol

9.0

16.4

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.9

16.4

240

1288

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

16.3

418

2666

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

4.5

16.3

127

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

16.3

225

1180

P01

ICPC

Feeling anxious/nervous/tense

1.8

16.3

281

1598

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

16.3

231

1225

N05AB01

ATC

dixyrazine; systemic

3.8

16.2

180

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.8

16.2

180

C09AA05

ATC

ramipril; oral

1.4

16.2

949

7249

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

16.2

184

895

2AB04

NOMESCO Finland

15.4

16.2

P20

ICPC

Memory disturbance

1.6

16.1

463

3042

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

9.2

16.1

G47.3

ICD-10 Finland

Sleep apnoea

1.4

16.1

755

5531

ZX120

NOMESCO Finland

Intravenous

1.7

16.0

351

2144

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.3

16.0

255

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

15.8

1657

13866

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.7

15.8

194

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.4

15.8

132

555

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

15.8

494

3316

G12.2

ICD-10 Finland

Motor neuron disease

6.6

15.8

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

15.8

168

791

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.6

15.8

118

468

SPAT1265

SPAT

Breathalyser

4.4

15.7

132

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.9

15.7

326

B01AA03

ATC

warfarin; systemic

1.4

15.7

806

6008

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.1

15.7

173

831

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

12.9

15.6

UJF32

NOMESCO Finland

Coloscopy

1.4

15.6

938

7190

RD210

NOMESCO Finland

3.2

15.6

266

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

15.6

105

392

N06AA10

ATC

nortriptyline; systemic

3.0

15.5

311

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

15.5

205

1059

SPAT1252

SPAT

Overall medication plan or its review

1.8

15.5

278

1599

J01EA01

ATC

trimethoprim; systemic

1.4

15.5

864

6535

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

15.5

378

2383

R11

ICD-10 Finland

Nausea and vomiting

1.8

15.4

293

1717

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

15.4

893

6802

L17

ICPC

Foot/toe symptom/complaint

1.4

15.4

884

6718

E000001

ATC

1.4

15.4

714

5214

N05CD02

ATC

nitrazepam; oral

3.0

15.4

295

RS142

NOMESCO Finland

12.3

15.3

WW400

NOMESCO Finland

Plasmaferesis

11.3

15.2

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

15.2

411

2659

SPAT1125

SPAT

Stoma care and guidance

3.1

15.2

282

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.0

15.2

151

Z29

ICPC

Social problem NOS

3.1

15.2

266

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

15.1

176

865

M25.5

ICD-10 Finland

Pain in joint

1.4

15.1

925

7109

B01AB05

ATC

enoxaparin; parenteral

1.4

14.9

1089

8611

H50.2

ICD-10 Finland

Vertical strabismus

5.3

14.9

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.2

14.9

247

K85

ICD-10 Finland

Acute pancreatitis

3.1

14.9

264

F31

ICD-10 Finland

Bipolar affective disorder

4.1

14.9

140

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

15.1

14.8

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

12.4

14.8

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.2

14.8

131

Z08

ICPC

Social welfare problem

3.6

14.8

185

SPAT1211

SPAT

Application of soft bandage

1.7

14.8

331

2037

K90

ICPC

Stroke/cerebrovascular accident

2.5

14.8

118

485

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.0

14.8

287

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

14.7

886

6781

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

11.3

14.7

C08CA01

ATC

amlodipine; oral

1.3

14.7

1339

10950

M79.7

ICD-10 Finland

Fibromyalgia

2.6

14.7

105

407

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

8.7

14.7

R4190

NOMESCO Finland

Nutritional therapy

2.4

14.7

127

545

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.2

14.7

154

725

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

7.4

14.6

G73.0*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic amyotrophy

+∞

14.6

33030

ICD-8 Finland

Hereditary neuromuscular disorders, Progressive muscular dystrophy

+∞

14.6

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.9

14.6

296

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

7.7

14.6

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

14.6

208

1108

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

14.2

14.5

R40.2

ICD-10 Finland

Coma, unspecified

4.1

14.5

134

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

6.7

14.5

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

14.4

177

887

G35

ICD-10 Finland

Multiple sclerosis

3.7

14.4

174

N06AB05

ATC

paroxetine; oral

1.9

14.3

202

1070

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

14.3

227

1252

RS221

NOMESCO Finland

3.2

14.3

233

N17

ICPC

Vertigo/dizziness

1.6

14.3

377

2425

G12.9

ICD-10 Finland

Spinal muscular atrophy, unspecified

27.2

14.3

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.7

14.2

100

6BA02

NOMESCO Finland

9.7

14.2

SPAT1139

SPAT

Nutrition survey

2.3

14.1

132

589

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

14.1

583

4155

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

14.1

367

2351

R1260

NOMESCO Finland

Evaluation of communicative skills

2.9

14.1

286

N06AX12

ATC

bupropion; oral

2.0

14.0

189

983

H25.8

ICD-10 Finland

Other senile cataract

1.6

14.0

403

2645

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

13.9

141

652

SPAT1053

SPAT

Memory test

1.5

13.9

562

3987

UKC02

NOMESCO Finland

Cystoscopy

1.5

13.9

605

4358

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.5

13.9

104

414

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

13.9

277

1649

N03AB02

ATC

phenytoin; systemic

3.4

13.8

196

N06AG02

ATC

moclobemide; oral

2.0

13.8

166

827

G12.1

ICD-10 Finland

Other inherited spinal muscular atrophy

53.5

13.8

D07AC01

ATC

betamethasone; topical

1.3

13.8

1190

9634

K59.0

ICD-10 Finland

Constipation

1.9

13.8

213

1168

ZXA00

NOMESCO Finland

Right side

1.3

13.7

989

7793

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

13.6

223

1243

H02AB04

ATC

methylprednisolone; systemic

1.5

13.6

508

3545

W10

ICD-10 Finland

Fall on and from stairs and steps

2.0

13.6

182

947

J01MA02

ATC

ciprofloxacin; systemic

1.3

13.6

1437

11970

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

5.2

13.6

G71

ICD-10 Finland

Primary disorders of muscles

+∞

13.5

G70.21

ICD-10 Finland

Limb girdle myasthenia

+∞

13.5

G73.7*M34.8

ICD-10 Finland

Myopathy in scleroderma

+∞

13.5

R27.0

ICD-10 Finland

Ataxia, unspecified

6.6

13.5

A02BC03

ATC

lansoprazole; oral

1.3

13.5

1061

8467

R25.2

ICD-10 Finland

Cramp and spasm

2.7

13.5

347

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

5.5

13.4

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.9

13.4

190

1009

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

13.3

134

618

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

6.6

13.2

TK810

NOMESCO Finland

Hemofiltration

4.9

13.2

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

13.1

491

3427

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.6

13.1

311

1943

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

15.1

13.1

L03

ICPC

Low back symptom/complaint

1.4

13.1

788

6024

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

4.4

12.9

106

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

12.9

268

1613

P28

ICPC

Limited function/disability (P)

4.9

12.9

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

13.0

12.9

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

12.9

217

1225

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

12.9

380

2514

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

12.8

375

2473

G71.1

ICD-10 Finland

Myotonic disorders

50.1

12.8

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

12.7

767

5854

L75

ICPC

Fracture: femur

3.3

12.7

188

Z50.5

ICD-10 Finland

Speech therapy

3.3

12.6

194

M54.1

ICD-10 Finland

Radiculopathy

2.2

12.6

134

633

SPAT1227

SPAT

Substance abuse rehabilitation

4.8

12.6

Z00.0

ICD-10 Finland

General medical examination

1.4

12.6

640

4743

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

12.3

12.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

12.6

403

2715

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.8

12.6

138

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

4.7

12.6

JN4AD

NOMESCO Finland

Body CT examination

1.7

12.5

273

1668

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

12.5

1389

11610

QBG00

NOMESCO Finland

Debridement of bedsore of trunk

17.3

12.5

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.2

12.5

123

564

A02BA02

ATC

ranitidine; systemic

1.4

12.5

715

5415

NJ3CM

NOMESCO Finland

Extensive MRI examination of extremities with 3 Tesla magnet

130.4

12.4

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.9

12.4

258

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

12.4

120

546

N05CD08

ATC

midazolam; nasal, systemic

2.5

12.4

379

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

12.3

230

1340

G04BD12

ATC

mirabegron; oral

1.6

12.3

356

2340

D01AC02

ATC

miconazole; topical

1.7

12.3

284

1759

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.2

12.3

198

K92.0

ICD-10 Finland

Haematemesis

2.4

12.3

103

438

R02

ICPC

Shortness of breath/dyspnoea

1.5

12.2

402

2729

H26.3

ICD-10 Finland

Drug-induced cataract

5.5

12.2

F20

ICD-10 Finland

Schizophrenia

4.8

12.2

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

4.3

12.1

104

K02.1

ICD-10 Finland

Caries of dentine

1.3

12.1

1904

16615

AA1XD

NOMESCO Finland

Other special CT of head and brain

5.8

12.1

N88

ICPC

Epilepsy

5.4

12.0

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

12.0

357

2362

N87

ICPC

Parkinsonism

3.1

12.0

202

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

12.0

157

812

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

8.7

12.0

F20.0

ICD-10 Finland

Paranoid schizophrenia

4.6

12.0

RF120

NOMESCO Finland

3.3

11.9

181

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

11.9

1493

12655

NC2AA

NOMESCO Finland

Forearm X-ray examination

3.5

11.9

160

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

11.9

247

1489

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.6

11.9

335

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.9

11.9

125

JN4BD

NOMESCO Finland

Extensive body CT

1.5

11.9

394

2678

X31

ICD-10 Finland

Exposure to excessive natural cold

6.8

11.9

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.5

11.9

362

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.7

11.8

312

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

11.8

221

C10AX09

ATC

ezetimibe; oral

1.5

11.8

377

2541

A10BA02

ATC

metformin; oral

1.3

11.8

1006

8099

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

11.8

387

2625

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

4.7

11.8

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

5.3

11.8

A10AE04

ATC

insulin glargine; parenteral

1.6

11.8

345

2276

X57

ICD-10 Finland

Unspecified privation

2.5

11.8

357

RF420

NOMESCO Finland

3.1

11.7

200

P76

ICPC

Depressive disorder

1.9

11.7

181

994

RF410

NOMESCO Finland

3.3

11.7

173

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.0

11.7

217

S72.0

ICD-10 Finland

Fracture of neck of femur

2.0

11.7

156

810

WX722

NOMESCO Finland

PEEP

1.9

11.7

182

1001

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.6

11.6

317

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.3

11.6

106

469

E87.5

ICD-10 Finland

Hyperkalaemia

2.7

11.6

280

E000003

ATC

1.9

11.5

159

838

NFM10

NOMESCO Finland

Fasciotomy of thigh

10.0

11.5

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

10.0

11.5

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.1

11.5

124

594

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

11.5

184

1022

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.9

11.5

231

Z99.1

ICD-10 Finland

Dependence on respirator

+∞

11.5

NK1AK

NOMESCO Finland

Spectroscopy of muscles

+∞

11.5

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.6

11.5

280

1765

NF3AA

NOMESCO Finland

Femur X-ray examination

2.7

11.4

297

G73.7*M05.3

ICD-10 Finland

Rheumatoid myopathy

120.3

11.4

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.7

11.4

284

K07

ICPC

Swollen ankles/oedema

1.9

11.4

164

876

SPAT1260

SPAT

Consultation of another employee

1.4

11.4

614

4594

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

11.4

457

3235

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

11.4

518

3759

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

4.6

11.3

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

7.9

11.3

RS220

NOMESCO Finland

3.0

11.3

206

SPAT1153

SPAT

Removal of sutures

1.3

11.3

1145

9434

P74

ICPC

Anxiety disorder/anxiety state

2.3

11.3

102

451

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

4.8

11.3

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

4.3

11.2

R03AC02

ATC

salbutamol; inhalant

1.3

11.2

1818

15868

N03AX11

ATC

topiramate; oral

2.6

11.2

313

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

5.1

11.2

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.5

11.1

351

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

11.1

379

2591

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

11.1

1738

15109

Z03

ICPC

Housing/neighbourhood problem

4.6

11.0

P27

ICPC

Fear of mental disorder

4.0

11.0

109

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

11.0

173

956

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

11.0

108

496

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

5.6

11.0

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.7

11.0

272

G11.9

ICD-10 Finland

Hereditary ataxia, unspecified

10.0

11.0

G60.0

ICD-10 Finland

Hereditary motor and sensory neuropathy

9.2

11.0

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

11.0

140

717

R35

ICD-10 Finland

Polyuria

1.7

10.9

221

1323

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.1

10.9

122

592

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.5

10.9

359

R5599

NOMESCO Finland

Other rehabilitation service

2.3

10.9

102

458

T90

ICPC

Diabetes non-insulin dependent

1.3

10.9

812

6402

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.5

10.9

146

G56.3

ICD-10 Finland

Lesion of radial nerve

4.1

10.9

101

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.7

10.9

275

WYA20

NOMESCO Finland

Home visit

2.8

10.8

252

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.7

10.8

268

A41.8

ICD-10 Finland

Other specified sepsis

2.7

10.8

268

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

10.8

979

7933

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

11.9

10.8

P19

ICPC

Drug abuse

4.5

10.8

L16

ICPC

Ankle symptom/complaint

1.6

10.8

321

2126

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.9

10.8

218

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

9.6

10.7

X84

ICD-10 Finland

Intentional self-harm by unspecified means

9.6

10.7

G44.2

ICD-10 Finland

Tension-type headache

1.5

10.7

387

2678

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.7

10.7

255

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.7

10.7

255

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

10.7

264

1669

M41.4

ICD-10 Finland

Neuromuscular scoliosis

21.5

10.7

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.0

10.6

207

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

10.6

921

7419

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

5.0

10.6

EBA30

NOMESCO Finland

Excision of root of tooth

1.8

10.6

193

1120

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

10.6

119

578

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

4.4

10.6

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

3.0

10.6

199

N19

ICD-10 Finland

Unspecified kidney failure

2.0

10.5

130

656

R03BB04

ATC

tiotropium bromide; inhalant

1.5

10.5

362

2479

N05AD03

ATC

melperone; systemic

2.8

10.5

228

R52.9

ICD-10 Finland

Pain, unspecified

1.6

10.5

275

1764

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

10.5

121

595

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

10.5

1256

10548

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

10.0

10.5

SPAT1243

SPAT

Psychiatric/psychological examination

2.4

10.5

386

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

10.4

667

5132

3592A

ICD-9 Finland

Muscular dystrophies and other myopathies, Myotonic disorders

+∞

10.4

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

10.4

219

1325

X78

ICD-10 Finland

Intentional self-harm by sharp object

5.2

10.4

5CM18

NOMESCO Finland

5.6

10.4

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

7.7

10.4

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

10.4

595

4497

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.6

10.3

290

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

10.3

178

1014

F03

ICD-10 Finland

Unspecified dementia

1.8

10.3

163

903

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.8

10.3

236

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

8.2

10.3

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

10.3

185

1069

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.4

10.3

335

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

10.3

1344

11405

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.1

10.3

117

573

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.0

10.3

201

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.4

10.2

336

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

23.4

10.2

XCK00

NOMESCO Finland

Perimetry

1.7

10.2

232

1435

XKC03

NOMESCO Finland

Water cystometry

2.1

10.2

114

553

ZXA05

NOMESCO Finland

Left side

1.3

10.2

903

7286

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

13.1

10.1

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

10.1

652

5018

F22.0

ICD-10 Finland

Delusional disorder

2.7

10.1

246

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.0

10.1

197

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

10.1

307

2045

Y96.9

ICD-10 Finland

Unspecified type of accident

2.7

10.1

257

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.9

10.1

211

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.4

10.1

344

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.8

10.0

228

S51.0

ICD-10 Finland

Open wound of elbow

3.2

10.0

162

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

10.0

160

891

G04BD08

ATC

solifenacin; oral

1.6

10.0

241

1517

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.9

10.0

147

797

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

40.1

10.0

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

10.0

439

A08

ICPC

Swelling

1.9

9.9

146

787

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.5

9.9

131

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

8.1

9.8

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

4.4

9.8

G82.2

ICD-10 Finland

Paraplegia, unspecified

5.4

9.8

F20.10

ICD-10 Finland

Raise schizophrenia continuously

5.7

9.8

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

9.8

780

6197

B01AC04

ATC

clopidogrel; oral

1.4

9.7

564

4264

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

9.5

9.7

RS121

NOMESCO Finland

4.2

9.7

SPAT1104

SPAT

Monitoring of emergency patient

1.6

9.7

237

1495

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

9.7

262

1696

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.3

9.7

378

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.0

9.7

128

665

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

9.7

240

1522

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

9.7

140

753

R52.1

ICD-10 Finland

Chronic intractable pain

3.7

9.7

108

RF432

NOMESCO Finland

55.1

9.6

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

9.6

113

563

J96.0

ICD-10 Finland

Acute respiratory failure

2.8

9.6

207

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.4

9.6

316

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

9.6

1591

13851

F20.5

ICD-10 Finland

Residual schizophrenia

4.5

9.5

F25

ICD-10 Finland

Schizoaffective disorders

8.4

9.5

R07.3

ICD-10 Finland

Other chest pain

1.5

9.5

305

2056

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

15.0

9.5

RS230

NOMESCO Finland

4.7

9.5

29999

ICD-8 Finland

Unspecified psychosis

5.7

9.5

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.9

9.5

190

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.7

9.5

176

1030

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.7

9.5

226

L04AD01

ATC

ciclosporin; systemic

2.6

9.4

268

H49.4

ICD-10 Finland

Progressive external ophthalmoplegia

100.2

9.4

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.7

9.4

191

1147

G73.1

ICD-10 Finland

Lambert-Eaton syndrome

+∞

9.4

73308

ICD-8 Finland

+∞

9.4

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

9.4

192

1154

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

4.6

9.4

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.1

9.4

106

520

OAB43

SPAT

0.6

9.3

194

2963

R5110

SPAT

2.2

9.3

439

TJD20

NOMESCO Finland

Change of gastrostomy tube

5.6

9.3

A07AA02

ATC

nystatin; oral

1.7

9.3

210

1297

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.2

9.3

406

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

8.0

9.3

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

9.3

216

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.2

9.3

149

F10.05

ICD-10 Finland

Alcohol-related acute intoxication with coma

10.7

9.3

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

9.5

9.2

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

9.5

9.2

M35.7

ICD-10 Finland

Hypermobility syndrome

3.4

9.2

128

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

9.2

368

M48.9

ICD-10 Finland

Spondylopathy, unspecified

4.5

9.2

M35.1

ICD-10 Finland

Other overlap syndromes

5.0

9.2

N03AX18

ATC

lacosamide; systemic

4.0

9.2

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

9.2

124

651

SPAT1244

SPAT

Occupational therapy

3.4

9.2

129

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.2

9.1

140

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

9.1

221

1392

L14

ICPC

Leg/thigh symptom/complaint

1.6

9.1

240

1545

F48.0

ICD-10 Finland

Neurasthenia

6.7

9.1

OAA80

SPAT

0.4

9.1

771

NH1AD

NOMESCO Finland

Ankle and foot CT

2.4

9.1

318

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

9.1

143

795

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

9.1

230

1469

M60.0

ICD-10 Finland

Infective myositis

15.6

9.0

IGV01

NOMESCO Finland

Psychiatric network contact

4.0

9.0

RS222

NOMESCO Finland

2.7

9.0

222

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.7

9.0

100

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

9.0

178

1062

M04AA01

ATC

allopurinol; systemic

1.4

8.9

472

3511

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.2

8.9

137

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

8.9

270

1798

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

18.6

8.9

H50.52

ICD-10 Finland

Exophoria

3.5

8.9

116

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

8.9

128

688

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.3

8.9

334

G20

ICD-10 Finland

Parkinson disease

1.9

8.9

122

646

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.4

8.9

296

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

8.9

126

675

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

8.9

124

662

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

4.8

8.8

G40

ICD-10 Finland

Epilepsy

3.5

8.8

112

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.7

8.8

219

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.6

8.8

102

N94

ICPC

Peripheral neuritis/neuropathy

8.6

8.8

ELA30

NOMESCO Finland

Biopsy of salivary gland

8.6

8.8

S80.0

ICD-10 Finland

Contusion of knee

1.7

8.8

183

1107

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

8.8

222

1415

SPAT1281

SPAT

Other administrative function

1.5

8.8

259

1716

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

9.5

8.8

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

4.6

8.8

SPAT1255

SPAT

Intravenous administration of medicine

1.6

8.8

222

1417

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.7

8.7

207

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

4.1

8.7

G93.4

ICD-10 Finland

Encephalopathy, unspecified

7.2

8.7

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

2.9

8.7

171

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

8.7

288

1957

N05AE04

ATC

ziprasidone; systemic

4.4

8.7

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.4

8.7

L84

ICD-10 Finland

Corns and callosities

1.9

8.7

122

651

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.8

8.7

151

868

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.2

8.7

386

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.3

8.6

130

M05BX04

ATC

denosumab; parenteral

1.8

8.6

154

891

S82.1

ICD-10 Finland

Fracture of upper end of tibia

2.5

8.6

259

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

8.6

188

1155

318

Kela drug reimbursment

Teriparatide

4.6

8.6

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.5

8.6

RS314

NOMESCO Finland

8.2

8.6

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

8.2

8.6

L04AA01

ATC

[U] ciclosporin; systemic

2.8

8.6

196

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.4

8.6

309

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.8

8.5

153

886

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.1

8.5

416

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.1

8.5

476

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.3

8.5

126

M01AX17

ATC

nimesulide; oral

1.3

8.5

831

6779

S72.4

ICD-10 Finland

Fracture of lower end of femur

3.6

8.5

100

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.9

8.5

116

613

30188

ICD-8 Finland

Personality disorders, Alia definita

4.5

8.5

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

8.4

480

P80

ICPC

Personality disorder

5.4

8.4

C07AB02

ATC

metoprolol; systemic

1.3

8.4

749

6031

H49.8

ICD-10 Finland

Other paralytic strabismus

90.2

8.4

R49.08

ICD-10 Finland

Other specified dysphonia

2.4

8.4

286

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

8.4

461

F44.4

ICD-10 Finland

Dissociative motor disorders

12.8

8.4

E51.2

ICD-10 Finland

Wernicke encephalopathy

12.8

8.4

N04BC05

ATC

pramipexole; oral

1.5

8.3

244

1614

G71.2

ICD-10 Finland

Congenital myopathies

+∞

8.3

3590A

ICD-9 Finland

Muscular dystrophies and other myopathies, Congenital hereditary muscular dystrophy

+∞

8.3

XG416

NOMESCO Finland

Measurement of maximal airway pressure

+∞

8.3

-1

NOMESCO Finland

1.3

8.3

1046

8792

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.1

8.3

145

D12

ICPC

Constipation

1.9

8.3

115

612

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

8.5

8.3

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

8.5

8.3

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

8.3

877

7222

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.6

8.3

227

E83.51

ICD-10 Finland

Hypocalcemia

4.3

8.3

G61.8

ICD-10 Finland

Other inflammatory polyneuropathies

10.7

8.3

D07AB08

ATC

desonide; topical

1.4

8.3

331

2341

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

9.4

8.3

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

8.3

183

1127

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.1

8.2

457

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

7.1

8.2

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

8.2

281

1926

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.2

8.2

343

CBJ30

NOMESCO Finland

Plastic repair of levator aponeurosis of eyelid

4.7

8.2

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.9

8.2

S43.0

ICD-10 Finland

Dislocation of shoulder joint

1.8

8.2

130

725

WX002

NOMESCO Finland

Sedation and analgesia

1.3

8.2

662

5260

J01MA14

ATC

moxifloxacin; systemic

1.5

8.2

283

1943

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.8

8.1

133

748

ZXA10

NOMESCO Finland

Bilateral

1.3

8.1

628

4961

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

5.4

8.1

WX320

NOMESCO Finland

Spinalanesthesy

1.3

8.1

754

6108

G04BD09

ATC

trospium; oral

2.1

8.1

427

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.1

8.1

427

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

8.1

536

4138

E66.8

ICD-10 Finland

Other obesity

1.7

8.1

151

887

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

2.9

8.1

164

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

8.1

149

873

G04CA02

ATC

tamsulosin; oral

1.3

8.1

854

7033

N06AB08

ATC

fluvoxamine; oral

2.1

8.1

442

S29

ICPC

Skin symptom/complaint other

1.3

8.1

534

4124

2910A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal delirium

6.8

8.0

N07

ICPC

Convulsion/seizure

6.8

8.0

RK110

NOMESCO Finland

3.1

8.0

132

A07DA03

ATC

loperamide; oral

1.8

8.0

130

729

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.3

8.0

116

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

8.0

157

937

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

5.5

8.0

A11CC03

ATC

alfacalcidol; systemic

2.1

8.0

414

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.1

7.9

J01CA08

ATC

pivmecillinam; oral

1.2

7.9

1158

9890

WZA90

NOMESCO Finland

Other doctors statement

1.3

7.9

711

5733

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.4

7.9

107

QBG10

NOMESCO Finland

Excision and repair of bedsore of trunk

13.0

7.9

RK322

NOMESCO Finland

13.0

7.9

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.2

7.8

118

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.2

7.8

118

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

5.1

7.8

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.4

7.8

260

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

7.8

504

3875

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

6.1

7.8

F05.8

ICD-10 Finland

Other delirium

3.8

7.8

N06AA04

ATC

clomipramine; systemic

2.4

7.8

253

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.9

7.8

156

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.3

7.8

312

SPAT1270

SPAT

Narcotic/sobriety test

9.4

7.8

AA400

NOMESCO Finland

Electroconvulsive therapy

3.4

7.8

103

K03.66

ICD-10 Finland

Tooth plaque

1.6

7.7

197

1260

R41.3

ICD-10 Finland

Other amnesia

2.0

7.7

505

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

7.7

1214

10447

U05

ICPC

Urination problems other

1.7

7.7

149

883

M41.9

ICD-10 Finland

Scoliosis, unspecified

2.9

7.7

158

N19

ICPC

Speech disorder

2.7

7.7

180

M01AH02

ATC

rofecoxib; oral

1.4

7.7

435

3275

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

5.9

7.7

Z00.8

ICD-10 Finland

Other general examinations

1.6

7.7

215

1410

RS130

NOMESCO Finland

7.4

7.7

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.9

7.6

152

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.0

7.6

143

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.8

7.6

125

706

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.3

7.6

309

SPAT1127

SPAT

Enema

3.2

7.6

121

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.0

7.6

474

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

7.6

113

617

S01XA18

ATC

ciclosporin; ophthalmic

4.2

7.6

Z82.0

ICD-10 Finland

Family history of epilepsy and other diseases of the nervous system

11.8

7.6

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.9

7.6

154

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.9

7.5

103

547

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

7.5

2400

22087

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.2

7.5

324

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

3.7

7.5

R15

ICD-10 Finland

Faecal incontinence

2.1

7.5

392

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

3.0

7.5

139

F41.00

ICD-10 Finland

Moderate panic disorder

2.7

7.5

177

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

5.7

7.5

SPAT1310

SPAT

Counselling related to known health issue

1.2

7.5

1068

9091

F32.8

ICD-10 Finland

Other depressive episodes

2.8

7.5

168

F21

ICPC

3.1

7.5

128

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.0

7.5

456

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

7.5

106

569

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

7.5

655

5261

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.9

7.5

149

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.9

7.5

149

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

2.9

7.4

140

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

3.5

7.4

D07XC01

ATC

betamethasone, combinations; topical

1.4

7.4

399

2977

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.7

7.4

145

865

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.8

7.4

163

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

7.4

361

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.4

7.4

183

Kela drug reimbursment

Lamotrigin and topiramate

3.0

7.4

129

XA100

NOMESCO Finland

Tensilon test

80.2

7.4

E88.8

ICD-10 Finland

Other specified metabolic disorders

80.2

7.4

NJ3BM

NOMESCO Finland

MRI examination of extremities with 3 Tesla magnet

80.2

7.4

C09AA02

ATC

enalapril; systemic

1.3

7.4

711

5780

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.2

7.4

G24.0

ICD-10 Finland

Drug-induced dystonia

13.4

7.4

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

7.6

7.4

RS140

NOMESCO Finland

7.6

7.4

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.7

7.4

146

875

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

6.0

7.4

Z43.5

ICD-10 Finland

Attention to cystostomy

4.0

7.4

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

7.3

480

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

7.3

133

774

NC1BA

NOMESCO Finland

Elbow extensive X-ray examination

3.8

7.3

RK220

NOMESCO Finland

4.7

7.3

A07AA09

ATC

vancomycin; oral

2.6

7.3

189

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

2.8

7.3

159

G71.21

ICD-10 Finland

Fibre type disproportion

+∞

7.3

G71.10

ICD-10 Finland

Myotonia drug-induced

+∞

7.3

H02AB13

ATC

deflazacort; oral

+∞

7.3

3598X

ICD-9 Finland

Muscular dystrophies and other myopathies, Other myopathies

+∞

7.3

B81

ICPC

Anaemia vit B12/folate deficiency

1.8

7.3

122

694

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

6.8

7.3

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

6.8

7.3

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

7.3

906

7595

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.8

7.3

120

680

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

4.9

7.3

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.3

7.3

284

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.8

7.2

160

G63.2

ICD-10 Finland

Diabetic polyneuropathy

3.9

7.2

C08CA05

ATC

nifedipine; systemic

1.5

7.2

225

1510

R52.0

ICD-10 Finland

Acute pain

1.9

7.2

490

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

7.2

123

702

G24.9

ICD-10 Finland

Dystonia, unspecified

5.4

7.2

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

5.8

7.2

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.0

7.2

426

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

7.2

285

2013

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

7.2

640

5149

SPAT1284

SPAT

Extensive health certificate

2.0

7.1

456

N06DA02

ATC

donepezil; oral

1.6

7.1

186

1199

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

7.1

267

1864

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

7.1

1821

16395

RS110

NOMESCO Finland

6.6

7.1

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

7.9

7.1

K92.1

ICD-10 Finland

Melaena

1.6

7.1

179

1143

WX1PA

NOMESCO Finland

Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)

12.0

7.1

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.5

7.1

205

XA400

NOMESCO Finland

EEG

3.5

7.1

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

5.3

7.1

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

8.8

7.0

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

7.0

221

1489

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.0

7.0

439

C08DA01

ATC

verapamil; systemic

1.7

7.0

144

871

H05AA02

ATC

teriparatide; parenteral

4.3

7.0

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.9

7.0

104

568

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

3.1

7.0

118

NB1AD

NOMESCO Finland

Shoulder CT examination

2.5

7.0

200

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

1.8

7.0

106

585

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.4

7.0

226

R25.3

ICD-10 Finland

Fasciculation

4.9

7.0

RS211

NOMESCO Finland

4.9

7.0

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.2

7.0

321

Z28

ICPC

Limited function/disability (Z)

4.0

7.0

A01AB09

ATC

miconazole; local oral

1.4

6.9

279

1976

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.9

6.9

498

C01BB02

ATC

mexiletine; systemic

6.3

6.9

Z72.0

ICD-10 Finland

Tobacco use

2.0

6.9

393

M05BA07

ATC

risedronic acid; oral

1.8

6.9

104

573

J02AC01

ATC

fluconazole; systemic

1.2

6.9

1159

10021

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.0

6.9

119

K29.2

ICD-10 Finland

Alcoholic gastritis

5.4

6.9

M02AA07

ATC

piroxicam; topical

1.2

6.9

1243

10825

Z11

ICPC

Compliance/being ill problem

3.4

6.9

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.2

6.9

302

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

6.9

153

947

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

13.8

6.9

G31.0

ICD-10 Finland

Circumscribed brain atrophy

4.6

6.9

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

4.6

6.9

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.5

6.9

224

1522

L60.0

ICD-10 Finland

Ingrowing nail

1.7

6.9

136

815

T00.9

ICD-10 Finland

Multiple superficial injuries, unspecified

3.5

6.9

SPAT1247

SPAT

Outpatient detoxication and monitoring

4.0

6.9

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

3.7

6.8

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.6

6.8

189

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.2

6.8

306

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

6.8

116

665

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.7

6.8

165

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

6.8

184

1199

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

6.8

123

719

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

6.8

346

2563

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

9.3

6.8

NF1DA

NOMESCO Finland

X-ray of hips

2.0

6.8

390

Y34

ICD-10 Finland

Unspecified event, undetermined intent

4.0

6.8

29530

ICD-8 Finland

Schizophrenia, Paranoid type

4.5

6.8

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

5.3

6.8

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.1

6.7

110

N05BA09

ATC

clobazam; oral

3.8

6.7

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.9

6.7

127

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.6

6.7

158

994

SBB10

NOMESCO Finland

Teeth copy

1.6

6.7

172

1104

S06.3

ICD-10 Finland

Focal brain injury

2.4

6.7

210

R03BA05

ATC

fluticasone; inhalant

1.3

6.7

554

4415

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

6.7

246

1717

G43.3

ICD-10 Finland

Complicated migraine

2.8

6.7

145

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

6.6

328

2415

Y94.8

ICD-10 Finland

Other leisure activity accident

2.0

6.6

440

M02AA10

ATC

ketoprofen; topical

1.3

6.6

493

3871

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

6.6

231

1589

SPAT1101

SPAT

Orthostatic test

1.6

6.6

147

909

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.7

6.6

123

722

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

6.6

584

4691

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

5.2

6.6

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

1.9

6.6

485

C10AC01

ATC

colestyramine; oral

2.0

6.6

429

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.7

6.6

121

709

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.4

6.6

224

E000006

ATC

1.5

6.6

210

1419

79309

ICD-8 Finland

Observation, without need for further medical care, Casus mentales alii sive NUD

12.2

6.6

FM2CE

NOMESCO Finland

4.6

6.6

RF210

NOMESCO Finland

1.9

6.6

474

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.0

6.5

368

M54

ICD-10 Finland

Dorsalgia

1.4

6.5

321

2359

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

10.0

6.5

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

10.0

6.5

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

4.3

6.5

N05AA03

ATC

promazine; systemic

6.8

6.5

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.0

6.5

383

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.7

6.5

148

S20.2

ICD-10 Finland

Contusion of thorax

1.6

6.5

154

973

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

6.5

300

2182

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.3

6.5

228

G04BD11

ATC

fesoterodine; oral

1.8

6.5

102

572

P05

ICPC

Senility, feeling/behaving old

3.8

6.5

G61.0

ICD-10 Finland

Guillain-Barré syndrome

4.5

6.4

M54.3

ICD-10 Finland

Sciatica

1.6

6.4

169

1090

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

5.3

6.4

R03AC13

ATC

formoterol; inhalant

1.6

6.4

150

940

K70.0

ICD-10 Finland

Alcoholic fatty liver

3.3

6.4

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.0

6.4

413

R06.4

ICD-10 Finland

Hyperventilation

2.3

6.4

229

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.1

6.4

103

NBH10

NOMESCO Finland

Reduction of dislocation of humeroscapular joint, closed

3.1

6.4

103

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2.9

6.4

129

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.6

6.4

167

F83

ICD-10 Finland

Mixed specific developmental disorders

4.7

6.4

Z82.6

ICD-10 Finland

Family history of arthritis and other diseases of the musculoskeletal system and connective tissue

14.3

6.4

D38.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thymus

14.3

6.4

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

2.8

6.4

137

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.0

6.4

365

N18.8

ICD-10 Finland

Other chronic renal failure

1.8

6.4

551

A03FA02

ATC

cisapride; oral, rectal

1.4

6.4

252

1782

R44.3

ICD-10 Finland

Hallucinations, unspecified

4.1

6.4

N06AX22

ATC

agomelatine; oral

2.2

6.4

263

L18

ICPC

Muscle pain

1.7

6.4

112

650

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.6

6.4

141

873

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

3.9

6.4

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.1

6.3

332

IAA01

SPAT

6.5

6.3

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

6.5

6.3

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

6.5

6.3

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.9

6.3

409

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

2.3

6.3

235

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

6.3

223

1544

E23.00

ICD-10 Finland

Panhypopituitarism

4.2

6.3

G95.9

ICD-10 Finland

Disease of spinal cord, unspecified

11.0

6.3

H50.8

ICD-10 Finland

Other specified strabismus

11.0

6.3

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

11.0

6.3

L88

ICPC

Rheumatoid/seropositive arthritis

1.7

6.3

111

643

W06

ICD-10 Finland

Fall involving bed

3.1

6.3

105

NFA20

NOMESCO Finland

Exploration of hip joint or femur

9.3

6.3

D15.0

ICD-10 Finland

Benign neoplasm: Thymus

18.0

6.3

WYA30

SPAT

3.8

6.3

OAA67

SPAT

0.6

6.3

1230

NJ3CF

NOMESCO Finland

Extensive MRI examination of extremities with median intensity magnet

+∞

6.2

G71.14

ICD-10 Finland

Paramyotonia congenita

+∞

6.2

N16.4*M32.1

ICD-10 Finland

Renal tubulo-interstitial disorders in systemic lupus erythematosus

+∞

6.2

G71.23

ICD-10 Finland

Disease central core

+∞

6.2

3589X

ICD-9 Finland

Myoneural disorders, unspecified

+∞

6.2

G73.0

ICD-10 Finland

Myasthenic syndromes in endocrine diseases

+∞

6.2

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

2.1

6.2

303

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.2

1229

10771

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

6.2

145

912

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.1

6.2

304

ACC53

NOMESCO Finland

Release of ulnar nerve

2.4

6.2

200

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.9

6.2

418

L73

ICPC

Fracture: tibia/fibula

2.5

6.2

182

S14

ICPC

Burn/scald

1.8

6.2

535

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

4.3

6.2

R40.0

ICD-10 Finland

Somnolence

4.8

6.2

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.1

6.2

293

R03DA04

ATC

theophylline; systemic, rectal

1.5

6.2

179

1186

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

6.2

261

1870

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

6.2

328

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

3.4

6.2

WX290

NOMESCO Finland

Other blockade of nerve

1.2

6.2

1328

11732

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.5

6.2

183

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

2.5

6.2

175

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

6.2

131

803

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

3.5

6.2

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

2.4

6.2

202

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.5

6.1

193

1300

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

4.5

6.1

RK120

NOMESCO Finland

4.5

6.1

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

6.1

781

6551

NA2AD

NOMESCO Finland

Thoracic spine CT examination

3.3

6.1

E46

ICD-10 Finland

Unspecified protein-energy malnutrition

7.7

6.1

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

7.7

6.1

I50.0

ICD-10 Finland

Congestive heart failure

1.4

6.1

258

1846

N06AA22

ATC

3.4

6.1

N02AC04

ATC

dextropropoxyphene; oral

1.7

6.1

130

795

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.1

6.1

288

D11

ICPC

Diarrhoea

1.4

6.1

292

2139

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.3

6.1

215

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.7

6.1

113

667

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

4.6

6.1

H53.3

ICD-10 Finland

Other disorders of binocular vision

4.6

6.1

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.5

6.1

185

1240

R25.1

ICD-10 Finland

Tremor, unspecified

1.8

6.1

518

N05AF01

ATC

flupentixol; systemic

2.2

6.1

268

A12AA04

ATC

calcium carbonate; oral

2.1

6.1

277

J86.9

ICD-10 Finland

Pyothorax without fistula

2.9

6.1

123

3AC01

NOMESCO Finland

2.7

6.0

137

R26.0

ICD-10 Finland

Ataxic gait

4.9

6.0

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

6.0

287

2099

L02

ICPC

Back symptom/complaint

1.4

6.0

246

1750

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

10.0

6.0

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

10.0

6.0

T42.4

ICD-10 Finland

Poisoning: Benzodiazepines

6.7

6.0

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

6.7

6.0

QDG30

NOMESCO Finland

Delayed skin closure of surgical wound in lower limb

6.7

6.0

V03AA02

ATC

6.7

6.0

NCM10

NOMESCO Finland

Fasciotomy of forearm

6.7

6.0

Z04.3

ICD-10 Finland

Examination and observation following other accident

2.0

6.0

366

A34

ICPC

General and Unspecified, Blood test

2.4

6.0

198

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

6.0

450

3536

N05BB01

ATC

hydroxyzine; systemic

1.5

6.0

196

1334

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.2

6.0

249

A05

ICPC

Feeling ill

1.6

6.0

155

999

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

279

199

14.82

308.11

1.9

1.4

9.0

6.5

u/l

1.10

227

169

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

343

188

19.56

307.65

1.3

1.1

12.4

0.8

nmol/l

5.13

166

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1169

1352

11.09

307.65

3.1

2.2

1804.8

367.0

ug/l

8.51

1095

1276

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3007

11992

5.00

307.65

4.9

2.1

1402.5

186.7

u/l

32.71

2867

11232

(3023368) Bacteria identified in Blood by Culture

2167

11259

2.68

235.98

5.5

4.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1464

6516

2.79

212.66

3.7

3.6

0.8

mmol/l

3.00

1346

6058

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3102

19794

2.59

211.48

9.9

7.0

1.2

mmol/l

5.40

2617

16695

(3023183) Ammonium ion [Moles/volume] in Plasma

429

851

5.44

206.52

3.2

2.9

30.3

36.6

umol/l

3.92

366

716

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1277

5369

2.87

205.85

6.2

6.1

1.1

1.0

mmol/l

1.57

1170

4986

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2865

17926

2.47

198.76

9.5

6.2

1.2

mmol/l

8.73

2653

16217

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

760

2691

3.17

163.34

5.1

4.1

5.2

kpa

1.45

714

2481

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

738

2569

3.21

163.24

5.1

4.0

1.6

1.8

mmol/l

0.61

584

1888

(3009343) pH of Capillary blood

751

2656

3.16

161.63

5.2

4.1

7.4

0.23

108

306

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1372

6664

2.48

159.80

2.2

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2662

17147

2.23

158.24

5.6

4.9

33.7

35.3

g/l

31.23

2431

15904

(42870588) Differential panel, method unspecified - Blood

2170

13308

2.15

140.76

8.1

5.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

870

3600

2.73

139.17

9.2

7.1

1.5

1.4

mmol/l

2.50

834

3451

(3013826) Glucose [Moles/volume] in Serum or Plasma

3226

23237

2.17

134.49

8.0

4.8

6.7

6.8

mmol/l

0.42

3101

21809

(3019309) Folate [Moles/volume] in Red Blood Cells

1454

7748

2.25

132.95

2.0

1.8

1192.7

1163.5

nmol/l

0.53

1088

5814

(3006315) Basophils [#/volume] in Blood

2792

19297

2.06

126.47

8.7

5.9

0.0

e9/l

2.91

2473

16576

(3001604) Monocytes [#/volume] in Blood

2782

19209

2.06

126.28

8.7

5.8

0.6

e9/l

2.77

2467

16484

(3013115) Eosinophils [#/volume] in Blood

2857

19932

2.06

125.86

9.2

6.1

0.2

e9/l

3.79

2530

17380

(3019069) Monocytes/100 leukocytes in Blood

2660

18180

2.03

122.90

9.4

6.4

8.7

8.8

0.14

2514

16983

(3006504) Eosinophils/100 leukocytes in Blood

2648

18083

2.03

122.46

9.0

6.1

2.6

2.9

8.49

2495

16817

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2888

20361

2.04

121.88

6.9

6.2

11.8

12.0

umol/l

0.36

2706

19299

(3020779) Urea [Moles/volume] in Serum or Plasma

860

3787

2.55

119.82

7.9

7.6

11.4

10.2

mmol/l

3.75

808

3599

(3019198) Lymphocytes [#/volume] in Blood

2817

19763

2.02

119.55

8.8

5.9

1.8

1.9

e9/l

1.14

2516

17287

(3022096) Basophils/100 leukocytes in Blood

2581

17584

2.01

118.78

9.0

6.1

0.6

0.7

4.43

2430

16379

(3026008) Bacteria identified in Urine by Culture

1905

11721

2.03

116.43

3.8

3.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

2689

18666

1.99

116.33

9.1

6.2

25.5

27.4

15.42

2518

17336

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

145

167

8.92

115.72

1.1

—

(3022313) Gas panel - Capillary blood

548

1944

3.05

115.42

5.6

4.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

499

1680

3.20

114.93

6.1

4.4

24.7

24.8

mmol/l

0.16

462

1552

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2305

15213

1.99

114.90

5.7

3.8

82.5

85.7

ng/l

0.03

1903

10877

(3018010) Neutrophils/100 leukocytes in Blood

2642

18385

1.97

111.67

8.8

6.0

59.5

57.5

12.61

2490

17157

(3031040) Bacteria [#/volume] in Urine by Automated count

3356

25411

2.05

110.67

6.4

4.6

949.6

2061.5

e6/l

0.93

398

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2400

16243

1.95

109.29

2.3

2.0

92.4

94.4

pmol/l

1.12

1366

8532

(3032080) INR in Blood by Coagulation assay

2411

16476

1.93

105.27

10.5

9.9

1.2

1.3

inr

3.02

639

4627

(3013650) Neutrophils [#/volume] in Blood by Automated count

3025

22319

1.95

104.38

12.5

8.9

4.5

4.2

e9/l

9.41

2700

19378

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3756

29932

2.15

103.86

9.9

7.5

81.1

79.8

u/l

0.82

3546

28150

(3012544) pH of Venous blood

872

4111

2.37

103.35

5.9

4.0

7.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

849

3970

2.38

102.43

5.9

4.0

5.9

5.8

kpa

1.45

814

3845

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1886

11962

1.95

102.20

3.5

3.1

2016.7

1620.3

ng/l

1.72

1598

10285

(3002032) Base excess in Venous blood by calculation

847

3962

2.38

102.09

5.9

4.1

2.0

mmol/l

0.13

713

3192

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

960

4743

2.28

101.83

9.6

7.3

5.2

5.1

kpa

1.75

921

4505

(3027801) Oxygen [Partial pressure] in Arterial blood

958

4742

2.27

101.09

9.6

7.3

11.4

12.2

kpa

5.56

918

4503

(3003396) Base excess in Arterial blood by calculation

956

4733

2.27

100.81

9.6

7.3

1.5

1.1

mmol/l

2.14

770

3664

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1908

12216

1.93

99.95

3.2

2.6

59.2

58.9

u/l

0.06

1750

11273

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1664

10203

1.96

98.89

2.6

2.3

3.1

3.0

mg/l

1.26

1382

8693

(3037522) Nuclear Ab [Titer] in Serum

950

4808

2.21

94.32

1.4

1.3

663.3

511.0

titre

1.49

240

1002

(3000991) Gas panel - Venous blood

755

3487

2.38

93.00

11.7

8.4

—

(3016502) Oxygen saturation in Arterial blood

863

4254

2.25

91.11

10.1

7.6

94.8

95.6

2.07

831

4083

(3022948) Iron [Moles/volume] in Serum or Plasma

1145

6363

2.05

88.38

2.7

2.5

11.5

12.9

umol/l

8.74

1021

5896

(3037467) Urinalysis macro (dipstick) panel - Urine

3371

26474

1.91

88.24

5.9

4.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2245

15591

1.82

87.50

2.8

2.3

75.1

77.5

nmol/l

2.90

1970

13921

(3036481) Cortisol [Moles/volume] in Serum or Plasma

731

3437

2.33

85.96

2.3

2.2

359.6

370.2

nmol/l

0.69

664

3143

(3018418) pH of Serum or Plasma

1795

11689

1.85

85.86

5.3

4.0

7.4

0.15

377

2238

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

426

1544

2.93

85.49

2.2

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

581

2482

2.52

84.44

1.9

1.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

722

3405

2.32

84.18

2.1

2.6

64.8

66.3

g/l

5.30

641

3089

(3007853) Bacteria identified in Skin by Aerobe culture

896

4636

2.15

83.10

2.3

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

774

3778

2.25

83.06

2.4

2.2

0.2

g/l

3.73

691

3513

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

643

2904

2.40

82.69

1.9

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

224

554

4.19

81.38

5.8

4.9

353.0

355.0

umol/l

0.07

193

481

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

443

1683

2.80

81.35

2.3

1.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

898

4694

2.12

80.90

3.1

4.2

263.4

247.0

u/l

2.00

824

4416

(3015377) Calcium [Moles/volume] in Serum or Plasma

1948

13184

1.80

80.79

3.1

3.4

2.3

2.4

mmol/l

8.65

1636

11444

(3024354) Oxygen [Partial pressure] in Venous blood

693

3279

2.30

79.91

5.5

3.5

4.7

4.6

kpa

0.72

655

3164

(3020191) Ethanol [Moles/volume] in Serum or Plasma

156

295

5.43

78.41

2.1

1.4

1.5

1.3

promille

0.90

132

230

(3021960) Folate [Moles/volume] in Serum or Plasma

1478

9274

1.86

77.99

1.8

1.6

18.7

20.3

nmol/l

3.60

1260

7913

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1052

5905

2.00

77.69

2.8

2.5

2.3

g/l

1.73

945

5458

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

548

2377

2.47

76.75

1.7

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

499

2076

2.57

76.34

6.9

4.3

23.9

24.1

mmol/l

1.04

456

1884

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

315

1027

3.21

75.80

2.6

1.5

0.2

g/l

2.80

304

970

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

831

4314

2.12

75.78

2.3

1.8

1.7

1.5

10.99

697

3781

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

321

1060

3.17

75.61

2.6

1.5

1.1

1.2

g/l

1.52

307

1000

(3004588) Protein electrophoresis panel - Serum or Plasma

615

2831

2.34

75.35

1.9

2.3

—

(3026782) Osmolality of Urine

1306

7952

1.88

75.32

3.5

2.8

522.7

552.5

mosm/kgh2o

5.47

1162

6776

(3005719) IgG [Mass/volume] in Serum or Plasma

621

2882

2.33

74.63

2.7

10.2

10.5

g/l

0.95

561

2619

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

992

5526

2.00

74.50

2.8

2.6

20.7

22.7

4.38

830

4702

(3019060) Gas panel - Arterial blood

603

2765

2.35

74.50

6.3

4.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

425

1694

2.65

70.78

2.3

1.9

2.4

2.3

ug/l

0.08

345

1486

(3019225) pH of Specimen

759

3929

2.11

69.24

5.8

4.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

852

4642

2.01

67.45

2.0

1.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2196

15991

1.68

65.91

3.4

2.9

165.2

140.9

ug/l

3.14

1986

14690

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

847

4640

2.00

65.89

2.0

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

281

932

3.14

65.57

1.5

1.4

535.3

542.2

mg/l

0.07

269

877

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

116

199

5.95

64.64

17.9

18.2

1340.0

1427.1

nmol/l

0.40

111

193

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

34.45

64.51

1.0

—

(3002582) Erythrocytes [#/volume] in Urine

1762

12192

1.70

63.39

4.3

3.3

40.8

101.8

e6/l

3.62

1459

9394

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

545

2559

2.27

63.19

9.4

7.8

24.8

24.9

mmol/l

0.24

536

2542

(3027945) Reticulocytes/100 erythrocytes in Blood

855

4763

1.97

63.14

2.4

2.6

1.8

0.91

716

4191

(3002173) Hemoglobin [Mass/volume] in Arterial blood

734

3897

2.04

62.02

11.3

8.1

121.3

121.6

g/l

0.16

708

3747

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

255

825

3.21

62.00

1.4

4.0

3.8

mmol/l

1.85

239

769

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

301

1076

2.92

61.53

2.6

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1774

12375

1.69

61.41

4.3

3.3

50.4

36.3

u/l

6.09

1657

11720

(3000850) Epithelial cells [#/volume] in Urine

1316

8479

1.76

60.74

3.4

2.6

5.6

5.2

e6/l

0.63

1199

7430

(1616796) Gas panel - Central venous blood

271

920

3.06

60.71

4.3

3.9

—

(3018095) Leukocytes [#/volume] in Urine

1950

14014

1.66

59.73

5.0

3.8

94.9

105.4

e6/l

0.25

1526

10053

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

237

751

3.27

59.62

1.4

1.2

2.1

11.4

u/ml

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

696

3688

2.04

58.92

2.8

2.4

13.3

7.5

ug/l

3.65

550

3224

(3030467) Casts [#/volume] in Urine by Automated count

1620

11128

1.69

58.85

4.3

3.2

0.6

0.5

e6/l

0.87

1321

8421

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3071

24826

1.65

57.97

4.9

3.1

66.0

51.7

u/l

6.88

2844

23017

(3013707) Erythrocyte sedimentation rate by Westergren method

3414

28371

1.69

57.83

5.4

4.1

15.0

12.6

mm/h

12.88

3130

26191

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

319

1216

2.74

57.76

1.4

1.3

—

(3012501) Base excess in Blood by calculation

265

918

3.00

57.27

5.5

4.6

2.6

2.7

mmol/l

0.25

193

632

(3027315) Oxygen [Partial pressure] in Blood

266

924

2.99

57.20

5.5

4.6

8.6

8.4

kpa

0.44

257

908

(3013290) Carbon dioxide [Partial pressure] in Blood

265

919

2.99

57.16

5.5

4.6

5.0

kpa

0.34

256

904

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

108

195

5.64

57.06

13.1

13.3

783.0

815.6

nmol/l

0.27

103

187

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

435

1934

2.37

57.05

1.7

1.5

g/l

1.96

359

1647

(3023520) Reticulocytes [#/volume] in Blood

668

3553

2.02

55.75

2.4

2.6

67.8

68.6

e9/l

0.25

497

2688

(36304419) Bacteria [Presence] in Urine

1569

10807

1.67

55.72

4.3

3.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

468

2175

2.28

55.32

11.5

9.5

24.7

24.3

mmol/l

1.54

433

2029

(3015171) Extractable nuclear Ab [Units/volume] in Serum

331

1317

2.62

55.01

1.3

1.2

1.7

0.9

u/ml

0.22

122

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

8.13

54.60

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

8.13

54.60

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

8.13

54.60

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

8.13

54.60

1.2

1.0

—

(3010421) pH of Blood

289

1080

2.78

54.31

5.4

4.5

7.4

0.15

256

903

(3003181) Sodium [Moles/volume] in Urine

222

728

3.15

52.72

1.5

1.4

56.9

64.4

mmol/l

1.65

163

585

(3028707) Methadone [Presence] in Urine by Screen method

177

507

3.59

52.14

3.3

3.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1022

6361

1.77

52.01

2.4

2.2

29.8

30.1

0.58

984

6171

(3028026) IgM [Mass/volume] in Serum or Plasma

472

2262

2.20

51.65

1.8

1.9

1.1

1.4

g/l

3.18

426

2043

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

167

5.78

51.63

2.1

2.4

166.5

116.5

umol/l

0.54

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

220

731

3.11

51.08

1.4

1.2

14.0

6.1

u/ml

0.32

(3015235) Bicarbonate [Moles/volume] in Capillary blood

282

1081

2.71

50.41

3.2

3.4

24.8

24.9

mmol/l

0.10

260

941

(3044640) Blood type and Crossmatch panel - Blood

1718

12388

1.60

49.30

3.1

2.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1257

8414

1.67

48.56

2.0

1.8

1.6

1.3

mg/l

1.66

967

6452

(3014271) Vancomycin [Susceptibility]

106

218

4.95

48.45

4.1

3.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

368

1635

2.35

48.13

1.3

1.5

17.0

19.2

u/ml

—

(3042936) Bacteria identified in Isolate by Culture

918

5651

1.77

48.10

2.6

2.0

—

(3044290) Cell count panel - Cerebral spinal fluid

220

758

2.99

47.94

1.7

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3376

28534

1.61

47.73

4.5

3.9

15.0

14.9

pmol/l

2.13

3056

25799

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

254

953

2.76

47.31

1.4

1.2

37.8

38.0

u/ml

0.01

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

230

821

2.89

47.03

1.6

1.5

13.7

23.7

e6/l

0.56

186

639

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

230

822

2.89

46.92

1.7

1.6

1480.3

1245.9

e6/l

0.11

193

676

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

242

896

2.79

46.22

1.4

1.2

6.4

7.8

u/ml

0.13

148

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

135

350

3.94

45.95

1.6

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

239

885

2.79

45.63

1.4

1.2

5.0

3.2

u/ml

0.46

(3014576) Chloride [Moles/volume] in Serum or Plasma

847

5199

1.76

44.47

11.1

6.9

103.9

104.4

mmol/l

1.75

828

5075

(3014007) Fractional oxyhemoglobin in Arterial blood

497

2580

2.03

43.84

12.6

9.1

93.2

93.9

1.38

491

2571

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

562

3049

1.95

43.71

4.2

4.0

96.4

93.0

ng/l

0.30

469

2617

(3028626) Oxygen [Partial pressure] in Capillary blood

265

1058

2.59

43.61

4.0

4.2

8.3

8.2

kpa

0.66

257

980

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1175

7918

1.64

43.43

4.9

3.8

276.5

532.0

ng/l

1.24

979

6393

(3008152) Bicarbonate [Moles/volume] in Arterial blood

501

2619

2.02

43.32

9.9

6.9

24.8

24.5

mmol/l

0.57

477

2435

(40767503) Oxygen content in Capillary blood by calculation

233

876

2.74

43.20

3.3

2.5

16.6

16.1

0.92

132

450

(40758558) Short blood count panel - Blood

1399

9867

1.59

42.72

8.4

6.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1353

9471

1.60

42.64

3.0

2.4

—

(3013512) EKG study

1573

11461

1.55

41.37

4.8

4.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

882

5587

1.71

41.05

24.2

26.7

1.4

inr

0.00

108

780

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

295

1294

2.36

39.60

2.6

3.3

35.0

61.6

mg/l

1.60

237

1048

(3034860) Kappa light chains.free [Mass/volume] in Serum

295

1296

2.36

39.46

2.6

3.3

48.3

105.5

mg/l

0.71

237

1046

(3033658) Prothrombin time (PT) actual/Normal

1401

10044

1.56

39.16

6.1

4.1

87.6

87.9

0.12

1356

9804

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1080

7301

1.62

38.77

3.0

3.1

2.5

mmol/l

0.19

904

6366

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3883

34556

1.63

38.48

5.6

4.6

1.9

2.1

mu/l

1.98

3558

31419

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

287

1261

2.36

38.37

2.6

3.3

1.9

2.2

ratio

0.14

(3011288) Drugs identified in Urine by Screen method

202

750

2.77

38.35

4.9

3.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1218

8500

1.58

38.14

1.7

23882556.2

28455596.1

pmol/l

0.12

984

7004

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

292

1298

2.33

38.00

1.6

373.3

269.8

titre

0.20

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4211

38343

1.77

37.54

27.7

15.1

27.3

25.0

mg/l

4.45

3771

30670

(3024928) Oxygen saturation in Venous blood

221

876

2.60

36.88

6.8

3.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

662

3980

1.77

36.78

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

332

1595

2.16

35.77

1.6

2.3

—

(3021901) Oxygen saturation in Capillary blood

204

789

2.66

35.77

2.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

332

1596

2.16

35.72

1.6

2.3

7.3

7.4

g/l

0.77

241

1181

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

246

1043

2.43

35.60

1.5

1.4

9.9

14.5

iu/ml

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

219

880

2.56

35.53

3.4

2.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

464

2528

1.92

35.33

6.0

3.4

127.7

128.5

g/l

0.30

456

2459

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

313

1481

2.19

35.03

1.6

2.3

3.2

3.1

g/l

0.61

236

1160

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

713

4436

1.71

34.95

3.5

2.9

9.6

8.9

umol/l

0.31

603

3862

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

323

1552

2.16

34.78

1.6

1.8

39.6

38.9

u/l

0.23

287

1359

(3052851) Hemolysis interference index of Serum or Plasma

266

1181

2.33

34.69

3.9

3.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

329

1594

2.14

34.68

1.6

2.3

3.6

3.8

g/l

1.84

230

1134

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

314

1494

2.18

34.66

1.6

2.3

9.9

10.3

g/l

0.85

254

1256

(3007164) IgA [Mass/volume] in Serum or Plasma

1023

6993

1.59

34.51

1.6

1.5

2.4

2.5

g/l

0.76

638

4191

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

185

4.55

34.50

1.8

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

126

381

3.37

34.19

1.9

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

272

1236

2.27

33.58

1.6

2.1

36.8

37.4

g/l

0.83

223

1057

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

198

4.35

33.43

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

387

2020

2.00

33.34

4.3

3.5

25.3

25.2

mmol/l

0.14

377

1954

(3019550) Sodium [Moles/volume] in Serum or Plasma

4291

39561

1.76

32.95

32.0

17.6

139.3

139.6

mmol/l

11.36

4219

38533

(46235355) HIV 1 and 2 tests - Meaningful Use set

854

5648

1.62

32.89

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

288

1353

2.20

32.79

1.7

2.3

0.4

1.0

g/l

4.60

239

1155

(3009261) Glucose [Presence] in Urine by Test strip

2322

18924

1.44

32.54

4.7

3.7

0.0

estimate

1.74

479

3399

(3035350) Ketones [Presence] in Urine by Test strip

2294

18658

1.44

32.48

4.6

3.7

0.0

estimate

0.80

484

3445

(3021601) Nitrite [Presence] in Urine by Test strip

2295

18693

1.43

32.10

6.1

5.0

0.0

estimate

0.50

503

3517

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

263

3.78

31.84

1.1

376.0

297.1

mg/l

0.84

224

(3023103) Potassium [Moles/volume] in Serum or Plasma

4293

39676

1.74

31.46

32.2

17.8

4.0

mmol/l

0.93

4222

38576

(3039162) Centromere protein B Ab [Units/volume] in Serum

130

422

3.14

31.43

1.4

1.2

36.9

46.1

u/ml

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

409

2222

1.92

31.29

15.0

10.1

—

(3021589) Normoblasts [#/volume] in Blood

2113

17029

1.43

30.92

14.8

9.9

0.0

e9/l

0.08

1746

13894

(3016879) Cocaine [Presence] in Urine

236

1047

2.32

30.82

3.7

2.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

272

3.66

30.33

1.2

1.1

51.1

43.3

mg/l

0.47

223

(3020891) Body temperature

326

1655

2.04

30.30

6.8

4.5

—

(3000764) Benzodiazepines [Presence] in Urine

246

1122

2.26

30.09

3.6

2.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

727

4718

1.64

29.98

1.7

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

981

6851

1.54

29.53

3.6

2.8

1.2

1.1

e6/l

0.34

600

3906

(4198724)

147

4.68

29.38

2.2

3.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

124

5.05

29.34

2.4

2.2

136.2

155.7

nmol/l

0.80

106

(3028300) Cannabinoids [Presence] in Urine

246

1134

2.23

29.33

3.6

2.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

172

678

2.59

29.05

1.4

1.2

47.2

44.0

u/ml

0.10

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

190

4.16

28.98

2.8

2.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

253

1188

2.19

28.82

1.7

2.2

0.0

g/l

0.75

230

1081

(3027008) Opiates [Presence] in Urine

244

1130

2.22

28.76

3.6

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2204

18058

1.41

28.55

4.8

4.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

240

1108

2.23

28.51

1.7

2.2

0.0

g/l

0.00

217

1006

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

108

333

3.29

28.45

1.1

—

(3023410) Appearance of Cerebral spinal fluid

114

365

3.17

28.24

2.0

1.9

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

203

883

2.36

27.74

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

203

883

2.36

27.74

1.4

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

350

1878

1.93

27.73

6.1

2.8

0.7

0.76

341

1800

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

251

3.63

27.68

1.1

—

(3037756) Immunofixation for Serum or Plasma

200

867

2.36

27.55

1.5

1.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

293

3.39

27.13

1.3

2.1

mmol/l

0.14

276

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

430

2489

1.80

26.80

2.5

2.4

30.6

23.1

au/ml

—

127

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

920

6456

1.53

26.78

3.8

3.0

3.3

2.2

e6/l

2.31

545

3541

(4027681)

202

3.91

26.69

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

233

1093

2.19

26.61

1.7

2.2

0.0

g/l

0.00

217

1005

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

578

3643

1.67

26.53

3.0

3.1

231.9

222.9

ng/l

0.16

521

3310

(3018405) Lactate [Moles/volume] in Arterial blood

289

1475

2.02

26.43

5.3

3.8

1.4

mmol/l

0.38

284

1450

(3047181) Lactate [Moles/volume] in Blood

259

1280

2.08

25.86

8.8

6.4

1.5

1.3

mmol/l

2.15

223

1127

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

284

1454

2.01

25.75

3.9

3.6

0.3

u/ml

1.49

157

840

(3002179) Metamyelocytes/100 leukocytes in Blood

493

3023

1.70

25.04

3.9

4.0

0.8

0.6

0.88

148

679

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

125

453

2.81

24.92

1.2

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

531

3328

1.67

24.83

4.1

0.9

0.15

186

962

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

571

3646

1.64

24.82

3.2

2.4

76.1

50.9

u/l

0.27

469

3119

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

391

2253

1.80

24.69

1.4

1.3

86.8

54.0

au/ml

—

(3017732) Neutrophils [#/volume] in Blood

438

2612

1.74

24.58

4.6

3.1

4.0

4.2

e9/l

0.54

302

2021

(3016650) Hepatitis A virus Ab [Presence] in Serum

145

578

2.56

23.97

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

118

424

2.83

23.91

1.5

1.4

283.6

278.6

mosm/kgh2o

1.01

312

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

193

3.77

23.51

1.1

u/l

0.32

102

(40760892) CBC W Ordered Manual Differential panel - Blood

1103

8211

1.44

23.49

6.1

4.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

504

3163

1.66

23.39

4.3

4.1

0.1

0.53

178

890

(3027944) Amphetamines [Presence] in Urine

226

1107

2.09

23.11

3.3

2.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

210

3.61

22.99

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

207

983

2.16

22.94

2.6

3.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

213

1028

2.12

22.64

1.2

1.3

138.6

97.4

titre

0.32

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

332

1874

1.83

22.41

5.1

4.1

51.2

48.7

1.15

326

1850

(3004616) Nuclear Ab [Presence] in Serum

118

442

2.71

22.12

1.3

—

(3025159) Blasts/100 leukocytes in Blood

473

2961

1.66

22.12

4.2

0.0

0.3

1.18

164

735

(3014148) Varicella zoster virus Ab [Titer] in Serum

111

403

2.80

22.09

1.1

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

625

4188

1.57

22.08

5.1

3.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

244

1252

2.00

21.98

5.8

4.0

3.8

3.9

mmol/l

0.76

236

1161

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

361

2106

1.77

21.82

2.8

3.3

4.3

4.5

pmol/l

1.37

308

1852

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

145

4.11

21.73

1.2

1.1

547.9

244.7

ng/l

0.29

(3000570) Elastase.pancreatic [Mass/mass] in Stool

224

1123

2.04

21.52

1.5

1.4

255.7

276.3

ug/g

0.79

125

666

(3029937) Albumin [Presence] in Urine by Test strip

1304

10143

1.39

21.31

5.1

4.1

0.0

estimate

1.54

457

3346

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

184

3.68

21.15

15.0

10.8

0.6

mmol/l

0.10

169

(3008757) Leukocyte morphology finding [Identifier] in Blood

116

442

2.66

21.05

3.7

4.1

—

(40761535) Cells panel - Urine sediment

505

3258

1.61

20.90

4.6

3.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

203

995

2.09

20.74

1.4

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

133

547

2.47

20.63

8.3

6.9

11.6

11.8

mg/l

0.17

116

512

(3011412) CD3 cells [#/volume] in Blood

101

362

2.83

20.61

2.7

2.5

1.1

e9/l

0.21

220

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

183

3.64

20.56

1.8

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

183

3.64

20.56

1.8

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

263

3.15

20.35

1.7

1.3

—

(3042517) Benzodiazepines panel - Urine

8.97

20.30

2.1

2.4

—

(3038026) Centromere Ab [Units/volume] in Serum

300

3.00

20.29

1.3

1.2

31.9

59.6

u/ml

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

138

582

2.41

20.28

1.6

0.6

0.8

g/l

2.92

105

451

(3017354) Segmented neutrophils/100 leukocytes in Blood

108

406

2.70

20.14

2.9

3.5

62.0

58.2

0.84

248

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

263

3.12

19.70

2.7

2.4

695.6

667.0

e6/l

0.13

108

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

258

3.14

19.68

1.7

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

191

934

2.09

19.64

2.4

2.2

130.9

128.3

g/l

0.73

159

669

(3006653) Thiamine [Moles/volume] in Blood

194

3.49

19.58

1.2

1.3

148.4

134.9

nmol/l

1.22

194

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

699

4917

1.49

19.55

12.5

7.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1157

8930

1.39

19.51

4.5

3.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

255

1386

1.89

19.39

2.5

2.6

—

(3016038) Potassium [Moles/volume] in Urine

271

3.06

19.36

1.3

31.8

35.4

mmol/l

0.79

236

(3034770) Mitochondria Ab [Titer] in Serum

203

1029

2.02

18.94

1.2

1.3

963.3

1155.0

titre

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

255

3.09

18.77

3.0

2.6

490.8

528.4

e6/l

0.24

214

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

277

2.99

18.65

1.3

1.2

2.0

3.8

u/ml

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

135

3.96

18.64

1.2

1.1

1755.8

1550.2

miu/ml

0.53

135

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

174

840

2.11

18.52

1.4

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

675

4764

1.48

18.50

4.4

4.5

32.5

32.3

0.17

477

3181

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

295

2.92

18.43

1.2

60.4

47.4

u/ml

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

150

684

2.23

18.43

1.6

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

4.21

18.32

1.2

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

292

2.91

18.17

1.3

1.2

84.5

69.2

u/ml

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1027

7854

1.39

18.11

1.3

1.9

u/ml

0.95

237

2010

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

495

3284

1.57

18.11

5.7

3.8

1.2

mmol/l

3.00

444

2867

(3037121) Protein [Mass/volume] in Urine

253

1405

1.84

17.99

3.1

3.2

0.4

0.3

g/l

0.69

125

606

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

105

4.32

17.78

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

114

4.15

17.67

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

244

3.06

17.57

3.0

2.7

0.2

e9/l

0.02

212

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

137

3.83

17.47

2.2

1.5

6317020.0

1471331.8

iu/ml

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

403

2571

1.62

17.38

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

107

4.24

17.36

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

279

2.90

17.22

2.3

13.8

13.7

0.04

129

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

102

404

2.56

17.19

2.7

2.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

206

1087

1.94

17.15

3.8

4.5

1.9

1.5

mg/l

4.03

185

999

(3009508) Creatinine [Moles/volume] in Urine

1527

12507

1.32

17.03

3.6

3.2

7.0

7.6

mmol/l

7.02

1262

10488

(3024522) Salmonella sp identified in Specimen by Organism specific culture

114

478

2.42

17.02

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

113

473

2.42

16.94

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2574

22622

1.30

16.92

3.1

2.8

—

(1761868) Lipid panel - Serum or Plasma

1005

12782

0.73

16.85

3.2

2.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

114

481

2.40

16.80

1.6

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

186

959

1.98

16.57

1.8

1.9

12.1

11.5

mg/l

0.32

173

885

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

147

3.63

16.56

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

111

469

2.40

16.31

1.6

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.69

16.31

1.2

—

(3025941) Bacteria identified in Stool by Culture

328

2019

1.67

16.29

1.4

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

189

986

1.95

16.28

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1717

14375

1.30

16.09

5.0

3.9

—

(3024869) Neuronal Ab [Presence] in Serum

4.82

15.87

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

110

469

2.38

15.86

1.6

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

138

3.65

15.75

2.8

2.7

28.9

29.4

umol/l

0.07

(3005988) Vibrio sp identified in Specimen by Organism specific culture

110

471

2.37

15.71

1.6

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.86

15.70

1.1

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.48

15.70

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

197

1057

1.90

15.62

1.4

1.3

—

(4035726)

494

3394

1.51

15.31

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

109

3.97

15.27

1.2

1.1

—

(40768797) Stomach Pathology biopsy report

714

5268

1.42

15.26

1.4

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

153

758

2.05

15.26

4.1

3.8

58.9

57.9

0.41

153

758

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

181

952

1.94

15.25

1.6

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

4.53

15.15

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

6.51

14.91

1.5

2.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

7.12

14.82

1.5

1.1

11.2

11.0

u/l

0.01

(3044927) Protein electrophoresis panel - Urine

416

2.41

14.77

1.4

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

200

3.08

14.68

1.4

1.5

—

(3000494) Fungus identified in Specimen by Culture

621

4498

1.44

14.68

1.6

1.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

148

736

2.04

14.63

4.0

3.5

4.3

4.2

e9/l

0.12

148

736

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

128

605

2.15

14.47

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

141

693

2.07

14.39

1.3

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

263

2.76

14.30

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

263

2.76

14.30

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

263

2.76

14.30

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

281

1722

1.67

14.20

8.2

5.3

1.7

1.6

0.66

260

1606

(3004809) Band form neutrophils/100 leukocytes in Blood

138

679

2.06

14.05

3.1

3.6

1.1

1.4

0.55

102

515

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

266

2.73

14.00

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

266

2.73

14.00

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

266

2.73

14.00

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

155

797

1.98

13.97

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

7.43

13.97

1.4

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

151

771

1.99

13.89

5.8

5.9

955.2

2432.2

iu/ml

0.34

115

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

126

603

2.12

13.81

1.5

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.72

13.75

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.24

13.73

1.2

1.1

—

(40761511) CBC panel - Blood by Automated count

4173

39608

1.39

13.64

25.8

14.2

—

(21494755) Public health laboratory ask at order entry panel

170

3027

0.55

13.61

1.3

1.4

—

(40761536) Microorganisms panel - Urine sediment

462

3210

1.49

13.52

5.3

4.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

106

478

2.24

13.48

1.5

1.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

362

2.43

13.30

1.5

1.4

2.9

g/l

0.01

259

(3023420) DNA double strand Ab [Units/volume] in Serum

363

2.42

13.22

2.3

1.3

24.2

26.1

iu/ml

0.14

(4062490)

364

2.42

13.14

1.5

1.4

—

(3019150) Specific gravity of Urine by Refractometry

1033

8258

1.32

13.08

5.2

4.1

1.0

kg/l

0.03

150

1230

(3040151) Glucose [Moles/volume] in Capillary blood

105

478

2.22

13.06

5.8

20.1

6.9

7.5

mmol/l

1.31

402

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

434

2.28

13.02

1.8

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

203

1165

1.78

13.01

4.9

2.9

3.4

3.5

g/l

0.64

195

1107

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.02

12.87

2.0

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

362

2.40

12.83

1.5

1.4

0.3

0.4

g/l

2.16

257

(3027135) IgG subclass 1 [Mass/volume] in Serum

362

2.40

12.83

1.5

1.4

5.9

6.7

g/l

1.57

258

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

206

1194

1.76

12.77

1.8

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

169

2956

0.56

12.70

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4253

40587

1.40

12.65

15.7

10.5

32.1

26.6

u/l

17.55

4119

39041

(3051611) Lipemic interference index of Serum or Plasma

403

2.31

12.55

3.5

3.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

196

1129

1.77

12.42

1.7

1.6

0.5

6.3

iu/ml

0.62

245

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

287

2.53

12.09

1.3

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

317

2.45

12.08

1.8

2.4

47.6

44.7

0.19

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

224

2.75

12.05

1.2

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

10.86

11.96

2.5

3.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.66

11.93

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.78

11.71

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

154

840

1.86

11.69

1.7

1.8

5.2

4.9

iu/l

0.09

280

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

138

727

1.92

11.65

1.6

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

398

2.26

11.60

1.8

1.7

—

(3039000) Anion gap in Blood

165

923

1.82

11.56

11.5

7.4

12.1

11.3

mmol/l

1.53

148

821

(3018572) Chloride [Moles/volume] in Blood

165

924

1.81

11.52

11.4

7.4

104.5

105.1

mmol/l

0.79

148

822

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

272

2.52

11.36

2.5

2.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

121

621

1.97

11.05

2.8

3.1

854.2

1757.0

u/ml

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3787

35724

1.28

10.77

22.9

14.2

80.5

79.1

ml/min/173m2

2.61

3312

29528

(3036489) Thrombin time

232

1456

1.62

10.73

2.6

2.4

22.4

21.6

0.99

205

1293

(3003434) Protein [Mass/volume] in Pleural fluid

115

590

1.97

10.53

1.5

31.2

31.9

g/l

0.20

106

527

(3007930) Methemoglobin/Hemoglobin.total in Blood

263

1710

1.57

10.49

8.5

5.4

0.9

0.43

246

1597

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

101

499

2.05

10.28

2.8

2.1

29.3

21.5

mg/l

0.65

120

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

116

604

1.94

10.19

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

251

2.49

10.14

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

125

670

1.89

10.07

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

107

544

1.99

10.07

1.3

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

177

2.79

10.04

1.1

6.3

75.2

70.4

mg/l

0.15

129

(3024891) Influenza virus A+B Ag [Presence] in Specimen

170

1003

1.72

9.97

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

156

2.90

9.94

1.1

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

181

1088

1.69

9.92

3.3

2.8

205.4

193.6

0.84

171

1038

(3013293) Extractable nuclear Ab [Presence] in Serum

4.53

9.76

1.8

1.7

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

4.70

9.75

4.4

5.1

48.3

48.8

ug/min

0.01

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

197

1218

1.64

9.70

2.8

89.1

90.2

0.25

184

1151

(36660697) Celiac disease serology panel - Serum

396

2853

1.42

9.55

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.17

9.45

3.9

7.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

104

536

1.96

9.44

1.3

1.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

17.55

9.39

1.1

1.0

—

mmol/l

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1236

10474

1.24

9.32

2.9

2.8

4596.9

5251.0

umol/l

0.21

1033

9041

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

169

2.74

9.16

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

107

1940

0.54

9.14

1.3

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

475

2.00

9.04

1.4

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

336

2.19

8.97

2.1

2.0

0.8

1.4

g/24h

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

318

2.22

8.88

1.1

1.2

92.9

169.5

titre

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3710

35152

1.24

8.75

6.7

5.9

40.4

40.2

mmol/mol

0.65

3369

32400

(3023199) Leukocytes [#/volume] in Pleural fluid

101

530

1.93

8.73

1.5

19467.7

2041.5

e6/l

1.15

384

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

203

2.53

8.70

2.1

3.0

101.2

95.0

0.49

194

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

107

574

1.88

8.66

1.3

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

152

2.78

8.63

3.8

2.7

—

(3032057) Clostridioides difficile [Presence] in Stool

3.31

8.60

2.0

—

(3023419) Bacteria identified in Sputum by Culture

100

526

1.92

8.59

2.1

2.6

—

(40768443) Skin Pathology biopsy report

246

1650

1.52

8.57

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

235

2.40

8.54

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

235

2.40

8.54

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1179

10020

1.23

8.53

4.3

3.4

—

(3000060) B lymphocytes [#/volume] in Blood

101

3.18

8.34

2.9

2.7

112.2

224.9

e6/l

1.58

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

112

3.05

8.26

3.1

2.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.52

8.23

1.2

0.6

0.7

umol/24h

0.80

(3017509) Phencyclidine [Presence] in Urine

5.35

8.20

2.6

1.3

—

(3017569) Oxygen content in Arterial blood

211

2.43

8.04

1.9

2.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

132

774

1.73

7.99

1.4

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

309

2201

1.43

7.96

1.4

1.3

252.7

231.6

u/ml

0.16

286

2011

(3030981) Hyaline casts [#/volume] in Urine by Automated count

301

2135

1.44

7.93

3.0

2.8

0.3

e6/l

0.13

295

2082

(4010399)

367

2696

1.39

7.92

1.5

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

148

2.72

7.91

1.6

2.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

328

2.12

7.87

1.4

1.6

—

(3012516) Albumin [Mass/volume] in Urine

1360

11816

1.21

7.80

3.4

3.2

609.1

325.6

mg/l

1.05

906

7585

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

310

2.14

7.76

2.5

19.0

19.5

nmol/l

0.15

291

(3028308) Erythrocytes [#/volume] in Pleural fluid

481

1.91

7.74

1.5

1.4

38594.5

75293.1

e6/l

1.10

291

(3012441) Differential panel - Pleural fluid

455

1.93

7.65

1.5

—

(3011985) Renin [Units/volume] in Plasma

520

1.86

7.59

1.4

45.5

59.5

mu/l

0.46

462

(3021387) Prolactin [Units/volume] in Serum or Plasma

162

1017

1.61

7.58

2.0

1.6

348.7

302.6

mu/l

0.73

146

935

(3028433) Virus identified in Specimen by Culture

135

2.75

7.53

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

219

2.34

7.44

3.2

2.6

44.3

38.6

1.22

(3019977) pH of Arterial blood

238

2.28

7.43

2.6

2.4

7.4

0.97

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.01

7.33

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

253

2.23

7.27

1.1

1.3

66.0

65.3

titre

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

241

2.25

7.22

1.5

1.6

4.2

6.5

u/l

0.82

115

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.93

7.15

2.4

2.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.93

7.15

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

396

1.96

7.13

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

740

6085

1.26

7.10

1.3

34.0

34.4

iu/ml

0.02

222

1889

(3048689) Calprotectin [Mass/mass] in Stool

541

4284

1.30

7.06

2.2

2.3

159.1

149.3

ug/g

0.23

426

3376

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

384

1.97

7.04

1.2

1.1

63.4

65.4

u/l

0.05

263

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.09

7.00

1.3

1.5

0.3

0.4

ug/l

0.67

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.86

6.97

2.4

2.3

—

(3051651) Icteric interference index of Serum or Plasma

240

2.22

6.87

3.5

3.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

494

1.84

6.86

1.4

—

(40768446) Kidney Pathology biopsy report

154

2.54

6.83

1.5

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

4.10

6.80

2.4

2.9

0.8

0.6

u/field

0.34

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

267

2.15

6.80

1.2

1.3

80.0

415.9

titre

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

348

2.00

6.77

1.8

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

348

2.00

6.77

1.8

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

348

2.00

6.77

1.8

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

230

2.23

6.68

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

528

1.80

6.66

1.1

1.6

1.5

g/l

0.29

471

(3028679) Herpes simplex virus Ab [Presence] in Serum

168

2.45

6.66

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

117

700

1.69

6.65

4.2

3.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

218

2.26

6.63

2.0

1.8

3.1

u/field

0.75

160

(3020682) Albumin/Creatinine [Ratio] in Urine

1412

12463

1.19

6.60

4.3

4.0

14.3

10.8

mg/mmol

0.97

900

7997

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

143

903

1.60

6.58

1.6

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.57

6.58

2.7

2.1

15.8

17.1

umol/l

0.25

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

116

695

1.69

6.57

1.4

1.5

103.3

115.7

u/ml

0.74

135

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.45

6.55

1.5

2.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

233

2.20

6.49

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

166

1091

1.54

6.44

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

348

1.97

6.43

1.1

1.2

—

(40768806) Pleura Pathology biopsy report

462

1.83

6.39

1.7

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

124

762

1.64

6.38

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

103

603

1.72

6.36

1.3

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

4.06

6.35

1.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.06

6.35

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

107

634

1.70

6.32

1.1

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

108

2.79

6.30

1.1

1.3

167.6

141.4

nmol/l

0.30

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

5.47

6.28

1.4

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

137

2.57

6.27

1.1

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

487

1.80

6.26

1.3

260.9

274.8

pmol/l

0.17

379

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

338

1.97

6.24

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

146

940

1.57

6.22

1.7

1.4

9.0

9.1

u/l

0.04

113

760

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

150

2.48

6.17

1.8

3.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

144

926

1.57

6.17

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.96

6.16

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

171

1146

1.51

6.08

1.8

1.7

—

(3042631) Mycobacterium sp identified in Specimen

566

1.73

6.07

2.3

2.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

166

1106

1.52

6.07

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

165

1098

1.52

6.07

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

307

2.00

6.07

1.2

1.5

31.8

24.8

u/ml

0.42

(3048929) Epstein Barr virus Ab [Presence] in Serum

163

1082

1.52

6.06

1.3

—

(3007461) Platelets [#/volume] in Blood

4350

42330

1.28

6.02

39.5

22.0

247.9

246.7

e9/l

0.53

4265

41154

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

546

1.74

5.99

1.4

1.3

0.5

0.3

nmol/l

0.19

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.93

5.99

1.1

1.2

—

(3024731) MCV [Entitic volume]

4351

42347

1.28

5.96

39.4

22.0

91.8

91.1

17.44

4294

41657

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.99

5.94

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

292

2170

1.37

5.93

1.3

1.2

112.4

144.8

iu/ml

0.66

778

(3010813) Leukocytes [#/volume] in Blood

4352

42363

1.28

5.92

39.6

22.1

7.2

6.8

e9/l

15.06

4267

41033

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

497

1.76

5.88

1.4

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

542

1.73

5.86

1.4

1.3

0.7

0.6

nmol/l

0.43

514

(3035941) MCH [Entitic mass]

4350

42349

1.27

5.85

39.3

21.9

30.4

1.45

4292

41659

(3000963) Hemoglobin [Mass/volume] in Blood

4351

42362

1.27

5.84

39.9

22.2

130.8

135.4

g/l

63.24

4289

41680

(3026361) Erythrocytes [#/volume] in Blood

4350

42353

1.27

5.82

39.5

22.0

4.3

4.5

e12/l

56.74

4260

41036

(44790049)

464

1.78

5.73

1.4

1.6

—

(44806118)

464

1.78

5.73

1.4

1.6

—

(44790047)

464

1.78

5.73

1.4

1.6

—

(44790048)

464

1.78

5.73

1.4

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

114

2.64

5.72

1.3

1.2

8.9

374.6

ug/l

0.84

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.79

5.72

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.54

5.59

1.1

1.2

25.3

57.6

—

(3049233) Organic acids panel - Urine

12.88

5.58

1.2

1.1

—

(3011648) Oxygen content in Venous blood

331

1.92

5.57

4.5

3.0

11.7

11.1

0.73

331

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.49

5.50

1.2

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

834

0.48

5.42

1.8

1.6

—

(3016750) Collection duration of Urine

238

2.07

5.40

2.2

2.0

511.1

490.5

min

0.69

173

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

114

718

1.60

5.38

1.3

306.0

272.7

u/ml

0.50

434

(3000093) Morphology [Interpretation] in Blood Narrative

386

1.83

5.35

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

423

1.79

5.33

1.9

2.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

309

1.92

5.29

1.0

276.3

286.3

mg/l

0.39

277

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

537

1.69

5.25

1.1

1.2

3.1

4.6

u/ml

1.12

241

(3027923) C peptide [Moles/volume] in Serum or Plasma

221

2.09

5.23

1.3

1.4

1.8

1.2

nmol/l

1.94

171

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

126

2.47

5.19

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.23

5.16

1.4

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

385

1.80

5.09

1.4

1.3

24.0

25.6

u/l

0.16

312

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3821

36831

1.18

5.06

5.1

4.6

6.1

6.0

mmol/l

2.39

3436

33360

(3004775) Volume in Urine collected for unspecified duration

329

1.87

5.02

2.3

2.2

682.0

629.0

0.51

210

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

552

1.66

5.01

1.1

1.2

3.1

4.4

u/ml

0.40

187

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

266

1.97

5.01

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

134

892

1.52

4.99

3.0

3.1

0.9

0.8

nmol/l

0.49

101

672

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

396

3154

1.28

4.96

3.1

2.6

66.8

64.4

ml/min/173m2

0.26

174

1277

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.74

4.93

1.3

1.1

210.0

294.0

pmol/l

0.84

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.07

4.78

1.7

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

5.01

4.77

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.28

4.74

1.1

—

(3045788) Cell count panel - Pleural fluid

418

1.73

4.68

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

127

2.37

4.64

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

480

1.68

4.62

1.3

—

nmol/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

139

949

1.48

4.61

1.4

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.22

4.61

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

3.34

4.60

1.5

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

157

1099

1.44

4.58

1.5

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

283

1.88

4.53

1.0

313.5

316.3

ng/l

0.02

191

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.06

4.51

1.2

1.4

135.3

78.6

ng/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

284

1.88

4.49

1.0

33.9

44.8

ng/l

1.53

188

(3045424) Erythrocytes [Presence] in Urine

100

644

1.56

4.37

1.4

1.5

—

(3007463) Buprenorphine [Presence] in Urine

7.51

4.35

12.6

4.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

7.51

4.35

1.6

1.0

1.9

2.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

11.68

4.27

1.3

2.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

140

973

1.45

4.27

1.7

1.6

13529.4

14199.7

e6/l

0.07

102

702

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

220

1.96

4.19

1.2

1.1

34.9

19.9

u/l

1.57

185

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

284

1.84

4.18

1.0

647.0

709.8

ng/l

0.41

186

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

207

1.99

4.15

2.1

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

207

1.99

4.15

2.1

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

207

1.99

4.15

2.1

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

207

1.99

4.15

2.1

1.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

221

1.95

4.14

1.3

1.6

—

(3003338) MCHC [Mass/volume]

3078

32151

0.88

4.13

34.8

19.4

330.9

332.5

g/l

16.51

3038

31852

(3022145) Colonoscopy Study observation

504

4216

1.22

4.10

1.4

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

222

1.95

4.10

1.3

1.6

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.35

4.08

1.5

2.8

3.3

mg/l

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.76

4.08

1.2

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

142

2.19

4.04

2.1

2.0

842.0

24339.5

u/ml

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

163

2.09

3.97

2.2

1.9

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.17

3.88

1.5

2.3

1.8

mg/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

117

804

1.47

3.82

2.1

2.2

3443.9

4112.8

u/l

0.11

314

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

273

2152

1.28

3.78

2.5

2.4

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

12.01

3.76

1.0

1.5

1.0

u/field

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

520

0.46

3.74

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

3585

34620

1.14

3.73

28.8

16.2

38.6

39.6

7.70

2194

24234

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

517

1.58

3.73

2.0

2.2

32.8

32.5

0.23

512

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

259

1.82

3.71

1.3

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

303

1.76

3.71

1.1

1.3

—

titre

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

161

2.06

3.70

2.2

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

161

2.06

3.70

2.2

1.9

—

(3044889) 12 lead EKG panel

2846

27132

1.12

3.60

4.5

3.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

262

1.80

3.59

1.9

1.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

484

0.45

3.58

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

483

0.45

3.57

1.4

—

(4015189)

2.35

3.57

3.0

2.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

482

0.45

3.55

1.4

—

(3045414) Leukocytes [Presence] in Urine

223

1727

1.31

3.55

1.9

2.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

134

959

1.41

3.55

1.1

3.5

7.2

u/ml

—

104

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

548

1.54

3.54

1.8

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

124

2.18

3.53

1.5

2.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

481

0.45

3.53

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.39

3.39

1.3

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

351

1.66

3.35

1.9

2.1

1.4

2.0

u/field

0.53

132

(3001019) Free T4 and TSH panel - Serum or Plasma

112

1573

0.71

3.34

1.8

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

659

5755

1.17

3.32

1.3

1.2

11.3

12.9

u/ml

0.20

216

2192

(3047352) Trisomy 18 risk [Likelihood] in Fetus

399

0.42

3.30

1.5

1.4

—

(4268621)

369

1.63

3.26

1.9

2.3

—

(3005033) Fetal Nuchal fold Thickness US

396

0.43

3.24

1.5

1.4

—

(4024509)

370

1.63

3.23

1.7

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

129

2.10

3.23

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

434

1.57

3.19

2.9

3.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

218

1711

1.29

3.17

1.3

—

(40757373) Influenza virus identified in Isolate

104

2.22

3.15

1.2

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

342

1.64

3.14

1.8

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

508

1.52

3.13

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

180

1.90

3.09

2.5

2.3

52.9

54.9

umol/l

0.12

142

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.08

1.9

1.2

—

14.8

—

(40768800) Prostate Pathology biopsy report

935

0.64

3.07

1.0

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

2.38

3.05

1.3

1.5

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

7.51

3.05

2.0

1.9

—

(3017704) Immunofixation for Urine

232

1.77

3.03

1.9

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

113

2.13

2.99

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

112

803

1.40

2.99

1.7

1.9

0.8

nmol/l

0.40

665

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

620

1.46

2.98

1.2

1.1

20.6

986.1

iu/ml

0.54

137

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

490

1.52

2.97

1.4

1.6

55.1

59.6

0.35

307

(3043238) Trisomy 21 risk [Likelihood] in Fetus

408

0.46

2.96

1.5

—

(3035880) pH of Pleural fluid

246

1.71

2.78

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

5.01

2.72

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.01

2.72

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

203

1.78

2.72

1.1

1.2

1.1

ratio

1.32

(3044941) Cell count panel - Synovial fluid

641

1.43

2.72

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

518

1.47

2.69

1.1

121.6

114.2

0.92

475

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

381

1.56

2.68

2.1

2.4

—

(3021788) Differential panel - Synovial fluid

101

727

1.40

2.67

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

244

2977

0.81

2.65

1.3

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.66

2.62

1.1

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

911

0.67

2.60

1.4

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

2.19

2.57

1.3

24.2

63.1

mu/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

114

2.02

2.55

2.2

1.8

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.36

2.55

1.0

1.1

—

(3036180) Methadone [Presence] in Urine

7.15

2.55

1.6

2.9

—

(4306422)

534

1.45

2.52

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.16

2.50

2.1

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

4.38

2.47

1.1

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.81

2.46

1.3

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

137

1.90

2.45

1.3

1.4

4.1

3.0

0.21

113

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.67

2.45

1.1

1.0

—

(3042733) HLA Ab [Presence] in Serum

130

1.93

2.45

4.8

4.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

303

1.59

2.43

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

6.25

2.37

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.12

2.36

1.3

1.5

22.3

15.7

nmol/l

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.61

2.35

1.0

1.2

25.1

20.6

u/l

—

(3000012) Reticulocyte production index

221

1.68

2.33

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.31

4.9

1.9

1.4

1.9

mmol/l

—

(3045716) Anion gap in Serum or Plasma

207

1.70

2.29

2.1

2.3

9.7

9.2

mmol/l

0.21

164

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.38

2.29

3.4

5.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.12

2.28

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.69

2.27

2.3

3.2

—

(3006270) Folate [Moles/volume] in Blood

357

1.52

2.26

1.3

1.2

364.9

354.8

nmol/l

0.14

301

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

538

1.42

2.26

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

366

1.51

2.24

1.0

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

5.56

2.21

1.0

—

(3047189) Immunofixation for 24 hour Urine

203

1.68

2.17

1.7

1.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.69

2.15

1.0

2.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.69

2.15

4.6

5.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

219

1.65

2.15

1.4

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

219

1.65

2.15

1.4

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

118

907

1.31

2.12

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

113

864

1.32

2.11

1.9

211.9

203.2

pmol/l

0.31

104

818

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

170

1370

1.25

2.10

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.56

2.09

1.2

1.3

1.9

1.8

umol/24h

0.17

(3001556) Androgen free Index in Serum or Plasma

3.20

2.09

1.9

1.1

—

(3036603) Volume of Urine

252

1.59

2.09

1.6

1.4

1401.6

1852.8

—

(3022621) pH of Urine by Test strip

304

2597

1.18

2.08

3.2

3.1

—

(3000492) Spirometry study

410

3590

1.16

2.06

1.6

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

214

1.64

2.06

2.0

3.3

31.6

25.6

mu/l

0.26

205

(3017446) Testosterone [Moles/volume] in Serum or Plasma

371

3225

1.16

2.05

2.6

2.2

12.1

12.8

nmol/l

0.98

323

2838

(3029075) Extractable nuclear Ab panel - Serum

103

1.95

2.05

1.2

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.40

2.02

1.0

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

3.08

2.01

1.1

—

38.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

400

4547

0.87

1.98

1.5

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

386

1.46

1.96

1.6

1.3

137807.8

114548.7

e6/l

0.11

269

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.34

1.96

1.4

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.34

1.96

1.0

2.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

172

1.69

1.92

1.3

1.4

58.6

63.0

0.26

136

(3023323) Follitropin [Units/volume] in Serum or Plasma

154

1242

1.25

1.92

1.6

1.4

22.3

28.3

iu/l

1.74

116

1047

(3002385) Erythrocyte distribution width [Ratio]

3232

31449

1.08

1.90

31.5

18.3

14.0

13.7

19.04

3175

30727

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.18

1.88

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.18

1.88

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

107

1.87

1.86

6.8

7.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.17

1.82

1.2

1.1

160.2

243.3

nmol/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

199

1.61

1.80

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

316

2749

1.16

1.77

1.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

396

1.42

1.75

1.4

0.2

0.3

nmol/l

2.15

301

(40768804) Tissue Pathology biopsy report

1607

15266

1.08

1.73

2.2

2.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

788

8534

0.91

1.71

2.7

3.0

0.7

0.8

ug/l

3.05

545

5727

(3034426) Prothrombin time (PT)

125

1.76

1.71

1.0

1.3

—

(3049717) Cytology report of Urine Cyto stain

194

1625

1.20

1.71

2.1

2.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.06

1.70

1.9

1.7

152.9

163.2

ng/l

0.09

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

125

1001

1.26

1.69

2.7

2.3

141.4

99.2

ug/min

0.49

614

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

145

1181

1.23

1.69

1.8

38.7

40.6

nmol/l

0.40

139

1140

(3006462) Nitrate [Presence] in Urine

187

1.61

1.68

5.3

3.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

366

1.43

1.68

1.5

1.3

1.5

nmol/l

0.02

330

(3036525) Urea [Moles/time] in 24 hour Urine

3.16

1.66

3.8

—

(3050794) Legionella sp Ab [Presence] in Serum

2.58

1.65

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

252

1.51

1.65

1.1

1.2

—

(4211845)

204

1.57

1.65

5.1

3.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

287

2496

1.16

1.63

1.6

1.7

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

105

1.81

1.62

1.2

104.9

103.2

0.08

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

545

0.68

1.59

3.6

3.8

126.6

31.6

u/ml

0.54

527

(4146454)

438

1.37

1.59

2.4

2.7

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.00

1.59

1.2

1.5

9.3

6.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.00

1.58

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

122

1.72

1.54

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

1.52

0.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.86

1.50

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

123

1.71

1.50

1.2

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

101

1.79

1.48

1.4

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

217

0.51

1.48

1.3

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

581

0.70

1.46

1.6

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.37

1.45

1.1

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

3.13

1.44

1.2

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

133

1.66

1.42

3.7

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

133

1.66

1.42

3.7

2.3

—

(44806071)

2.25

1.40

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.85

1.40

1.4

1.8

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.42

1.39

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.77

1.38

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.77

1.38

5.6

7.9

—

(3051593) INR in Capillary blood by Coagulation assay

206

1.51

1.37

3.8

12.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

247

1.46

1.37

1.2

1.4

0.5

1.1

u/ml

0.62

114

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.80

1.37

2.9

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

104

1.73

1.36

1.1

94.1

88.2

0.40

(1761482) Bacteria [#/volume] in Urine by Culture

127

1048

1.22

1.36

5.1

4.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

391

1.36

1.35

1.0

1.1

97.1

94.8

0.22

371

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

698

1.27

1.35

1.2

21.6

47.2

u/l

3.09

606

(3006442) Creatine [Moles/volume] in Serum or Plasma

265

1.44

1.34

2.0

1.6

53.4

74.1

umol/l

1.88

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

307

1.40

1.33

1.4

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

454

4131

1.11

1.31

3.1

4.0

15.1

24.1

ug/l

0.86

358

3379

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

377

1.36

1.30

1.3

1.5

14.2

29.0

3.65

225

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

339

3037

1.13

1.30

2.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.78

1.28

1.0

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

114

1.67

1.28

1.1

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

114

1.67

1.28

1.6

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

107

875

1.23

1.27

1.3

268.4

212.1

miu/ml

0.56

372

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.29

1.26

7.0

4.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.00

1.23

1.3

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.77

1.22

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

514

1.29

1.20

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

156

1.54

1.20

1.0

1.1

98.3

94.1

0.14

126

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.31

1.18

4.3

5.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

109

1.65

1.18

1.1

1.3

—

(3014891) Appearance of Pleural fluid

1.88

1.18

1.4

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

102

1.67

1.16

5.5

6.2

71.0

73.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

232

1.43

1.14

1.4

2.0

—

(3026470) Cobalt [Mass/volume] in Blood

250

1.40

1.12

1.8

2.0

2.7

3.1

ug/l

0.25

219

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

119

1.60

1.11

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

143

1.54

1.11

2.0

2.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.71

1.11

1.7

2.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

104

1.64

1.09

1.1

1.3

95.8

86.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.92

1.06

1.1

2.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.27

1.03

1.6

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.06

1.02

1.3

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.06

1.02

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.74

1.02

1.5

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.74

1.02

5.8

8.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

107

1.59

0.99

1.1

1.4

30.0

31.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

123

1.55

0.99

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

139

1198

1.17

0.99

1.7

1.9

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.71

0.98

1.0

1.1

—

7.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.18

0.98

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3652

37021

0.94

0.97

4.7

4.4

1.4

mmol/l

4.48

3282

33945

(3033799) Differential panel - Peritoneal fluid

125

1.52

0.93

2.9

2.1

—

(3022689) Creatine [Moles/volume] in Urine

119

0.50

0.93

1.3

1.4

—

(3048879) Bone marrow aspiration report

117

1.54

0.93

1.7

—

(3025315) Body weight

2.22

0.93

5.2

3.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

260

1.35

0.93

2.6

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.63

0.90

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

151

1.46

0.90

1.1

1.5

—

(3024263) Appearance of Synovial fluid

219

1.37

0.89

1.4

1.6

—

(3004451) EKG impression Narrative

219

1.37

0.89

1.1

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

152

0.59

0.88

1.1

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

638

1.21

0.88

1.5

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

1.86

0.87

1.0

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

521

1.23

0.87

3.7

2.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

503

1.24

0.87

1.3

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1535

14843

1.05

0.87

4.3

4.9

3.4

3.7

ug/l

0.17

1351

13300

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1140

11871

0.95

0.86

3.7

4.2

21.9

0.05

537

5807

(3044009) aPTT.lupus sensitive (LA screen)

1.94

0.84

1.3

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

179

1.40

0.83

1.2

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

111

0.54

0.83

1.0

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.61

0.81

2.1

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3531

35767

0.95

0.80

4.3

4.0

1.4

1.3

mmol/l

12.33

3159

32546

(1617658) Protocol used for examination of sentinel lymph nodes

259

0.69

0.79

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.78

0.0

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.62

0.78

1.8

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

165

1.40

0.77

1.9

1.7

4.9

7.8

nmol/l

0.35

138

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.77

0.76

4.3

2.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

105

1208

0.87

0.75

1.6

1.7

4.6

4.0

mg/l

0.13

855

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.67

0.74

16.1

13.2

3.7

6.0

mmol/l

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.00

0.72

1.0

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.80

0.72

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

607

5755

1.06

0.72

1.5

—

(3015183) Erythrocyte sedimentation rate

171

0.64

0.72

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

409

1.22

0.69

1.5

1.3

—

(3044007) Cell count panel - Peritoneal fluid

118

1.44

0.69

3.3

2.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

144

1.39

0.67

2.7

2.3

970.1

5508.2

e6/l

0.46

112

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

190

0.68

0.65

1.0

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

137

1.39

0.64

1.3

75.9

58.6

1.70

113

(3038177) Helicobacter pylori Ab [Presence] in Serum

580

1.17

0.62

1.2

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.60

0.61

1.9

1.6

43.1

42.8

umol/l

—

(3025577) Chromium [Mass/volume] in Blood

244

1.27

0.61

1.8

2.1

1.8

1.9

ug/l

0.19

208

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

289

1.25

0.60

2.0

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

183

1.31

0.59

1.2

1.3

5.9

6.0

mmol/l

0.17

175

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.58

0.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.46

0.58

2.5

2.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.48

0.57

1.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

839

0.87

0.56

1.4

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

124

1.37

0.55

1.5

1.2

47.0

38.9

g/l

—

(3020491) Glucose [Moles/volume] in Blood

296

0.78

0.55

1.6

2.3

6.3

6.8

mmol/l

1.04

199

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3700

37332

0.96

0.54

4.7

4.5

4.6

mmol/l

6.40

3344

34434

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

223

1.26

0.52

2.9

4.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.46

0.50

1.0

1.1

—

(3001729) Color of Synovial fluid

1.46

0.50

1.3

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

945

0.89

0.49

1.2

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

212

0.75

0.48

5.8

6.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

111

1.35

0.46

1.4

9.8

8.9

ug/l

0.40

111

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

151

1639

0.92

0.46

2.9

3.4

58.0

61.7

u/ml

0.07

146

1577

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

366

3849

0.95

0.45

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

552

1.14

0.45

2.7

4.8

611.7

u/ml

0.68

530

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.43

0.45

1.0

1.2

—

98.4

—

(3014051) Protein [Presence] in Urine by Test strip

100

904

1.11

0.44

2.4

2.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.43

0.42

1.4

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.43

0.42

1.4

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.43

0.42

1.4

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.56

0.42

1.6

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.38

0.42

1.6

2.2

6.2

7.9

mmol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.38

0.42

1.3

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

212

1.23

0.42

1.1

1.2

—

(3019174) dRVVT (LA screen)

1.52

0.41

1.4

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

195

1.23

0.40

1.3

1.4

0.8

4.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3787

38123

0.97

0.39

5.1

5.0

2.6

2.7

mmol/l

7.77

3411

34974

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

306

1.18

0.39

3.4

4.9

62.5

78.9

u/ml

—

(3000330) Specific gravity of Urine by Test strip

217

2043

1.07

0.39

4.5

3.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

228

2411

0.94

0.37

1.1

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

107

1.31

0.37

1.1

1.5

11.5

13.2

g/l

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

262

1.18

0.37

2.4

1.6

1.0

0.9

g/l

0.62

262

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

135

0.74

0.36

1.5

2.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.27

0.36

3.7

2.9

—

(3024471) HLA-A [Type]

135

1.26

0.35

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

112

1211

0.92

0.35

1.7

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

728

1.10

0.34

1.4

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.33

0.33

1.3

—

(4133840)

0.67

0.32

1.5

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

151

1417

1.07

0.32

2.8

3.3

103.5

3817.8

u/ml

1.18

129

1211

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

316

0.85

0.31

1.4

1.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.35

0.31

1.0

1.1

73.3

71.6

ug/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

839

1.09

0.31

2.3

3.4

386.1

806.4

u/ml

0.55

775

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

456

1.12

0.31

2.9

3.3

3.9

17.7

nmol/l

0.60

445

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

156

1.22

0.31

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

514

0.89

0.29

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

269

1.15

0.29

2.2

2.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

130

1.23

0.28

2.6

2.1

860.4

17386.8

e6/l

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

270

1.15

0.28

1.3

11.9

12.0

mmol/l

0.02

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

214

1.17

0.27

2.1

144.0

273.3

ug/min

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

116

0.78

0.27

2.9

3.3

—

106.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.23

0.27

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.28

0.26

1.3

1.2

—

(40768441) Liver Pathology biopsy report

272

1.14

0.26

1.8

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

197

1.17

0.25

1.0

1.7

—

8.4

—

(3024932) HLA-DR beta [Type]

132

1.21

0.25

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

207

1.16

0.25

4.1

3.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

160

1523

1.05

0.24

1.9

2.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.74

0.24

2.7

1.8

—

54.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.32

0.23

6.2

2.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.32

0.23

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

380

1.11

0.23

1.5

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

515

0.91

0.22

1.1

—

(3020650) Glucose [Presence] in Urine

0.76

0.22

1.1

1.5

—

(4034850)

116

1225

0.95

0.22

14.2

10.5

—

(1002224) Polysomnography panel

136

1429

0.95

0.22

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

283

0.88

0.21

1.8

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.16

0.21

1.2

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.20

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.20

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.20

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.20

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.20

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.22

0.20

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

993

10075

0.98

0.20

1.7

1.6

1.4

mmol/l

4.55

853

8458

(3045142) Bone marrow Pathology biopsy report

469

0.92

0.20

1.0

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

176

0.85

0.19

1.1

35.8

3.0

u/ml

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.20

0.19

2.0

6.5

15.0

1035.7

g/mol

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

353

0.91

0.18

1.1

0.5

0.3

u/ml

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.21

0.18

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.13

0.17

1.3

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

379

1.08

0.16

1.1

2.7

4.7

u/ml

0.59

156

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

467

1.07

0.15

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

183

1772

1.03

0.15

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.76

0.15

2.7

1.5

—

(40768795) Lymph node Pathology biopsy report

368

0.92

0.14

1.1

1.2

—

(3008898) HLA-B27 [Presence]

116

1116

1.04

0.14

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

110

0.82

0.13

1.0

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

200

0.90

0.12

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

230

1.09

0.11

1.0

1.1

9.7

10.0

iu/ml

—

(3002256) Pathology report gross observation

496

5028

0.98

0.11

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

387

1.06

0.10

2.6

2.9

46.4

59.2

mg/l

0.19

297

(3034274) Bile acid [Moles/volume] in Serum --fasting

309

1.07

0.10

1.8

2.3

17.7

9.7

umol/l

0.34

212

(3013727) Leukocytes other/100 leukocytes in Blood

144

1.11

0.10

5.5

3.9

56.3

55.0

0.09

138

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.14

0.10

40.8

10.9

—

(4212803)

1.11

0.09

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

309

0.94

0.09

1.3

1.4

51.4

155.3

pmol/l

0.57

(3000285) Sodium [Moles/volume] in Blood

0.79

0.08

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.03

0.07

1.1

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.86

0.07

1.0

—

(40765096) Chromosome analysis panel by Banding

122

0.90

0.07

1.0

1.1

—

(44806420)

132

0.91

0.06

2.7

2.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

139

1.08

0.05

1.9

2.0

—

(40768793) Breast Pathology biopsy report

756

0.98

0.04

1.4

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

554

0.97

0.04

1.1

5.7

5.3

u/ml

0.05

290

(3051387) C reactive protein [Mass/volume] in Capillary blood

894

1.02

0.04

3.7

3.6

27.1

28.1

mg/l

0.08

566

(3003694) ABO and Rh group [Type] in Blood

1019

10221

1.00

0.03

1.3

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

171

1.05

0.03

1.2

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

410

0.98

0.02

1.1

3.8

2.8

u/ml

0.15

167

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

469

0.98

0.02

1.1

1.5

2.7

u/ml

—

187

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

332

1.02

0.01

1.0

1.2

—

(4094501)

104

1048

0.99

0.01

1.1

—

(44813793)

224

1.03

0.00

1.1

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

145

1.03

0.00

1.7

1.6

9.0

8.2

mmol/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

428

1.00

0.00

1.3

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

235

0.98

0.00

1.1

—

(21494434) Karyotype in Bone marrow

375

1.01

0.00

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

385

1.01

0.00

1.6

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

445

1.01

0.00

1.2

1.3

8.0

7.3

mmol/l

0.70

333

(3010726) Horse dander IgE Ab [Units/volume] in Serum

505

1.01

0.00

1.1

0.9

2.3

u/ml

1.38

126

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

143

0.98

0.00

1.1

—

(3025130) Human papilloma virus identified in Specimen

353

0.99

0.00

1.8

1.7

—

(4281824)

367

1.01

0.00

1.4

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

623

1.00

0.00

1.2

1.1

1.2

1.8

u/ml

0.50

260

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

119

1.01

0.00

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

541

1.00

0.00

1.1

1.0

1.5

u/ml

0.24

242

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.93

0.00

1.6

1.5

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

142.9

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1432.9

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

5.9

—

63.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.7

—

0.2

—

(40758292) HTLV I+II Ab panel - Serum

1.02

0.00

1.2

1.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

120

1.00

0.00

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.94

0.00

1.2

1.9

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.8

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.4

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MYONEU and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_MYONEU	2.179 [1.94, 2.45]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.026

During the follow-up period (1.1.1998 — 31.12.2019), 5630 out of 15018 females with G6_MYONEU died.

Males

Parameter	HR [95% CI]	p-value
G6_MYONEU	2.996 [2.64, 3.4]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 7312 out of 17909 males with G6_MYONEU died.

Mortality risk

Mortality risk for people of age

years, who have G6_MYONEU.

N-year risk	Females	Males
1	0.158%	0.431%
5	1.15%	3.041%
10	2.834%	7.753%
15	5.241%	15.018%
20	9.066%	25.303%

Relationships between endpoints

↥

Index endpoint: G6_MYONEU – Diseases of the myoneural junction and muscle

GWS hits: 17

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diseases of the myoneural junction and muscle

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints